Loading...
Reach Banner
Keywords
Last name
Institution

Victor Blanchette

TitleStaff Physician
InstitutionThe Hospital for Sick Children
DepartmentHaematology/Oncology
Address555 University Avenue
Toronto ON M5G 1X8
Phone416-813-1500
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Gouw SC, Timmer MA, Srivastava A, de Kleijn P, Hilliard P, Peters M, Blanchette V, Fischer K. Measurement of joint health in persons with haemophilia: A systematic review of the measurement properties of haemophilia-specific instruments. Haemophilia. 2018 Nov 14. PMID: 30427100.
      View in: PubMed
    2. Beck CE, Carcao M, Cada M, Porter S, Blanchette VS, Parkin PC. A Quality Improvement Bundle to Improve Informed Choice for Children With Typical, Newly Diagnosed Immune Thrombocytopenia. J Pediatr Hematol Oncol. 2018 Nov; 40(8):e537-e543. PMID: 30028824.
      View in: PubMed
    3. Gibson TN, Beeput S, Gaspard J, George C, Gibson D, Jackson N, Leandre-Broome V, Palmer-Mitchell N, Alexis C, Bird-Compton J, Bodkyn C, Boyle R, McLean-Salmon S, Reece-Mills M, Quee-Brown CS, Allen U, Weitzman S, Blanchette V, Gupta S. Baseline characteristics and outcomes of children with cancer in the English-speaking Caribbean: A multinational retrospective cohort. Pediatr Blood Cancer. 2018 Dec; 65(12):e27298. PMID: 30094928.
      View in: PubMed
    4. Chen ZP, Li PJ, Li G, Tang L, Zhen YZ, Wu XY, Cheng XL, Luke KH, Blanchette VS, Poon MC, Ding QL, Wu RH. Pharmacokinetic Studies of Factor VIII in Chinese Boys with Severe Hemophilia A: A Single-Center Study. Chin Med J (Engl). 2018 Aug 05; 131(15):1780-1785. PMID: 29848837.
      View in: PubMed
    5. Wharfe G, Buchner-Daley L, Gibson T, Hilliard P, Usuba K, Abad A, Boma-Fischer L, Bouskill V, Floros G, Lillicrap D, Lowe Y, Lowe D, Palmer-Mitchell N, Rand ML, Teitel J, Tuttle A, Watson A, White R, Young NL, Blanchette VS. The Jamaican Haemophilia Registry: Describing the burden of disease. Haemophilia. 2018 Jul; 24(4):e179-e186. PMID: 29855125.
      View in: PubMed
    6. Iorio A, Edginton AN, Blanchette V, Blatny J, Boban A, Cnossen M, Collins P, Croteau SE, Fischer K, Hart DP, Ito S, Korth-Bradley J, Lethagen S, Lillicrap D, Makris M, Mathôt R, Morfini M, Neufeld EJ, Spears J. Performing and interpreting individual pharmacokinetic profiles in patients with Hemophilia A or B: Rationale and general considerations. Res Pract Thromb Haemost. 2018 Jul; 2(3):535-548. PMID: 30046759.
      View in: PubMed
    7. Hermans C, Mahlangu J, Booth J, Schütz H, Santagostino E, Young G, Lee HY, Steinitz-Trost KN, Blanchette V, Berntorp E. Pharmacokinetic modelling and validation of the half-life extension needed to reduce the burden of infusions compared with standard factor VIII. Haemophilia. 2018 May; 24(3):376-384. PMID: 29732708.
      View in: PubMed
    8. Stokhuijzen E, Rand ML, Cnossen MH, Biss TT, James PD, Suijker MH, Peters M, van der Lee JH, Peters B, Meijer AB, Blanchette VS, Fijnvandraat K. Identifying Children with HEreditary Coagulation disorders (iCHEC): a protocol for a prospective cohort study. BMJ Open. 2018 May 03; 8(5):e020686. PMID: 29724741.
      View in: PubMed
    9. Feldman BM, Rivard GE, Babyn P, Wu JKM, Steele M, Poon MC, Card RT, Israels SJ, Laferriere N, Gill K, Chan AK, Carcao M, Klaassen RJ, Cloutier S, Price VE, Dover S, Blanchette VS. Tailored frequency-escalated primary prophylaxis for severe haemophilia A: results of the 16-year Canadian Hemophilia Prophylaxis Study longitudinal cohort. Lancet Haematol. 2018 Jun; 5(6):e252-e260. PMID: 29731369.
      View in: PubMed
    10. Mahlangu J, Young G, Hermans C, Blanchette V, Berntorp E, Santagostino E. Defining extended half-life rFVIII-A critical review of the evidence. Haemophilia. 2018 May; 24(3):348-358. PMID: 29633467.
      View in: PubMed
    11. Stokhuijzen E, Segbefia CI, Biss TT, Clark DS, James PD, Riddel J, Blanchette VS, Rand ML. Severity and Features of Epistaxis in Children with a Mucocutaneous Bleeding Disorder. J Pediatr. 2018 Feb; 193:183-189.e2. PMID: 29198540.
      View in: PubMed
    12. Timmer MA, Gouw SC, Feldman BM, Zwagemaker A, de Kleijn P, Pisters MF, Schutgens REG, Blanchette V, Srivastava A, David JA, Fischer K, van der Net J. Measuring activities and participation in persons with haemophilia: A systematic review of commonly used instruments. Haemophilia. 2018 Mar; 24(2):e33-e49. PMID: 29178149.
      View in: PubMed
    13. Iorio A, Blanchette V, Blatny J, Collins P, Fischer K, Neufeld E. Estimating and interpreting the pharmacokinetic profiles of individual patients with hemophilia A or B using a population pharmacokinetic approach: communication from the SSC of the ISTH. J Thromb Haemost. 2017 12; 15(12):2461-2465. PMID: 29119666.
      View in: PubMed
    14. Oldenburg J, Kulkarni R, Srivastava A, Mahlangu JN, Blanchette VS, Tsao E, Winding B, Dumont J, Jain N. Improved joint health in subjects with severe haemophilia A treated prophylactically with recombinant factor VIII Fc fusion protein. Haemophilia. 2018 Jan; 24(1):77-84. PMID: 29082639.
      View in: PubMed
    15. Pakdeeto S, Natesirinilkul R, Komwilaisak P, Rand ML, Blanchette VS, Vallibhakara SA, Sirachainan N. Development of a Thai version of the paediatric bleeding assessment tool (Thai paediatric-BAT) suitable for use in children with inherited mucocutaneous bleeding disorders. Haemophilia. 2017 11; 23(6):e539-e542. PMID: 28994494.
      View in: PubMed
    16. Tang L, Xu W, Li CG, Hou F, Feng XQ, Wang H, Li XJ, Li WL, Liu JP, Sun LR, Wang SH, Jin J, Fang Q, Luke KH, Poon MC, Blanchette VS, Usuba K, Young NL, Wu R. Describing the quality of life of boys with haemophilia in China: Results of a multicentre study using the CHO-KLAT. Haemophilia. 2018 Jan; 24(1):113-119. PMID: 28922525.
      View in: PubMed
    17. Soliman M, Daruge P, Dertkigil SSJ, De Avila Fernandes E, Negrao JR, de Aguiar Vilela Mitraud S, Sakuma ETI, Fernandes ARC, Zhang N, Huo A, Li YJ, Zhou F, Rodrigues BM, Mohanta A, Blanchette VS, Doria AS. Imaging of haemophilic arthropathy in growing joints: pitfalls in ultrasound and MRI. Haemophilia. 2017 Sep; 23(5):660-672. PMID: 28574216.
      View in: PubMed
    18. Al-Battat S, Rand ML, Bouskill V, Lau W, Blanchette VS, Kahr WHA, Rivard GE, Carcao MD. Glanzmann thrombasthenia platelets compete with transfused platelets, reducing the haemostatic impact of platelet transfusions. Br J Haematol. 2018 May; 181(3):410-413. PMID: 28466602.
      View in: PubMed
    19. Casey LJ, Tuttle A, Grabell J, Hopman W, Moorehead PC, Blanchette VS, Wu JK, Steele M, Klaassen RJ, Silva M, Rand ML, James PD. Generation and optimization of the self-administered pediatric bleeding questionnaire and its validation as a screening tool for von Willebrand disease. Pediatr Blood Cancer. 2017 Oct; 64(10). PMID: 28453185.
      View in: PubMed
    20. Carcao MD, Avila L, Leissinger C, Blanchette VS, Aledort L. An International Prophylaxis Study Group (IPSG) survey of prophylaxis in inhibitor positive children/adults with severe haemophilia. Haemophilia. 2017 09; 23(5):e444-e447. PMID: 28439934.
      View in: PubMed
    21. Carneiro JDA, Blanchette V, Ozelo MC, Antunes SV, Villaca PR, Young NL, Castro D, Brandão LR, Carcao M, Abad A, Feldman BM. Comparing the burden of illness of haemophilia between resource-constrained and unconstrained countries: the São Paulo-Toronto Hemophilia Study. Haemophilia. 2017 Sep; 23(5):682-688. PMID: 28440005.
      View in: PubMed
    22. Limperg PF, Terwee CB, Young NL, Price VE, Gouw SC, Peters M, Grootenhuis MA, Blanchette V, Haverman L. Health-related quality of life questionnaires in individuals with haemophilia: a systematic review of their measurement properties. Haemophilia. 2017 Jul; 23(4):497-510. PMID: 28429867.
      View in: PubMed
    23. Carcao MD, Avila L, Leissinger C, Blanchette VS, Aledort L. An International Prophylaxis Study Group (IPSG) survey of prophylaxis in adults with severe haemophilia. Haemophilia. 2017 09; 23(5):e447-e450. PMID: 28429874.
      View in: PubMed
    24. Ligocki CC, Abadeh A, Wang KC, Adams-Webber T, Blanchette VS, Doria AS. A systematic review of ultrasound imaging as a tool for evaluating haemophilic arthropathy in children and adults. Haemophilia. 2017 Jul; 23(4):598-612. PMID: 28429878.
      View in: PubMed
    25. Labarque V, Perinparajah V, Bouskill V, Stain AM, Wakefield C, Manuel C, Blanchette VS, James PD, Lillicrap D, Carcao MD. Utility of factor VIII and factor VIII to von Willebrand factor ratio in identifying 277 unselected carriers of hemophilia A. Am J Hematol. 2017 06; 92(6):E94-E96. PMID: 28249352.
      View in: PubMed
    26. Iorio A, Fischer K, Blanchette V, Rangarajan S, Young G, Morfini M. Tailoring treatment of haemophilia B: accounting for the distribution and clearance of standard and extended half-life FIX concentrates. Thromb Haemost. 2017 06 02; 117(6):1023-1030. PMID: 28357444.
      View in: PubMed
    27. Carcao M, Kearney S, Santagostino E, Oyesiku JOO, Young NL, Meunier J, Hoxer CS, Zhang C, Blanchette VS. Insight into health-related quality of life of young children with haemophilia B treated with long-acting nonacog beta pegol recombinant factor IX. Haemophilia. 2017 05; 23(3):e222-e224. PMID: 28371032.
      View in: PubMed
    28. Wu R, Sun J, Xiao J, Liu Y, Xue F, Wang H, Tang L, Zhao Y, Li K, Yang R, Hu Y, Luke KH, Poon MC, Blanchette VS, Usuba K, Young NL. A prospective study of health-related quality of life of boys with severe haemophilia A in China: comparing on-demand to prophylaxis treatment. Haemophilia. 2017 May; 23(3):430-436. PMID: 28345299.
      View in: PubMed
    29. Iorio A, Iserman E, Blanchette V, Dolan G, Escuriola Ettingshausen C, Hermans C, Negrier C, Oldenburg J, Reininger A, Rodriguez-Merchan C, Spannagl M, Valentino LA, Young G, Steinitz-Trost KN, Gringeri A. Target plasma factor levels for personalized treatment in haemophilia: a Delphi consensus statement. Haemophilia. 2017 May; 23(3):e170-e179. PMID: 28345268.
      View in: PubMed
    30. Urban D, Pluthero FG, Christensen H, Baidya S, Rand ML, Das A, Shah PS, Chitayat D, Blanchette VS, Kahr WH. Decreased numbers of dense granules in fetal and neonatal platelets. Haematologica. 2017 02; 102(2):e36-e38. PMID: 27810994.
      View in: PubMed
    31. Fischer K, Poonnoose P, Dunn AL, Babyn P, Manco-Johnson MJ, David JA, van der Net J, Feldman B, Berger K, Carcao M, de Kleijn P, Silva M, Hilliard P, Doria A, Srivastava A, Blanchette V. Choosing outcome assessment tools in haemophilia care and research: a multidisciplinary perspective. Haemophilia. 2017 Jan; 23(1):11-24. PMID: 27633342.
      View in: PubMed
    32. Crivianu-Gaita V, Rivard GE, Carcao M, Teitel J, St-Louis J, Blanchette V, Pullenayegum E, Abad A, Feldman BM. Pilot study of once-a-day prophylaxis for youth and young adults with severe haemophilia A. Haemophilia. 2016 Sep; 22(5):e401-5. PMID: 27481574.
      View in: PubMed
    33. Villaça PR, Blanchette VS, Carneiro JD, Ozelo MC, Antunes S, Feldman BM, Abad A, Usuba K, Young NL. Validity of the Portuguese CHO-KLAT in Brazil. Haemophilia. 2016 Nov; 22(6):894-897. PMID: 27456858.
      View in: PubMed
    34. Collins PW, Hamilton M, Dunstan FD, Maguire S, Nuttall DE, Liesner R, Thomas AE, Hanley J, Chalmers E, Blanchette V, Kemp AM. Patterns of bruising in preschool children with inherited bleeding disorders: a longitudinal study. Arch Dis Child. 2017 12; 102(12):1110-1117. PMID: 27449675.
      View in: PubMed
    35. Poonnoose PM, Hilliard P, Doria AS, Keshava SN, Gibikote S, Kavitha ML, Feldman BM, Blanchette V, Srivastava A. Correlating clinical and radiological assessment of joints in haemophilia: results of a cross sectional study. Haemophilia. 2016 Nov; 22(6):925-933. PMID: 27385495.
      View in: PubMed
    36. St-Louis J, Urajnik DJ, Ménard F, Cloutier S, Klaassen RJ, Ritchie B, Rivard GE, Warner M, Blanchette V, Young NL. Generic and disease-specific quality of life among youth and young men with Hemophilia in Canada. BMC Hematol. 2016; 16:13. PMID: 27158500; PMCID: PMC4858890.
    37. Tarantino MD, Bussel JB, Blanchette VS, Despotovic J, Bennett C, Raj A, Williams B, Beam D, Morales J, Rose MJ, Carpenter N, Nie K, Eisen M. Romiplostim in children with immune thrombocytopenia: a phase 3, randomised, double-blind, placebo-controlled study. Lancet. 2016 Jul 02; 388(10039):45-54. PMID: 27103127.
      View in: PubMed
    38. van den Berg HM, Feldman B, Fischer K, Blanchette VS, Poonnoose P, Srivastava A. Reply to the letter of O'Mahoney et al.: Patient-reported outcome is not confined to HRQOL. Haemophilia. 2016 05; 22(3):e209-11. PMID: 27076036.
      View in: PubMed
    39. Fischer K, Collins PW, Ozelo MC, Srivastava A, Young G, Blanchette VS. When and how to start prophylaxis in boys with severe hemophilia without inhibitors: communication from the SSC of the ISTH. J Thromb Haemost. 2016 05; 14(5):1105-9. PMID: 27186714.
      View in: PubMed
    40. Mathias SD, Li X, Eisen M, Carpenter N, Crosby RD, Blanchette VS. A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Effect of Romiplostim on Health-Related Quality of Life in Children with Primary Immune Thrombocytopenia and Associated Burden in Their Parents. Pediatr Blood Cancer. 2016 Jul; 63(7):1232-7. PMID: 27037553.
      View in: PubMed
    41. Berger KC, Feldman BM, Wasserman J, Schramm W, Blanchette V, Fischer K. Securing reimbursement for patient centered haemophilia care: major collaborative efforts are needed. Haematologica. 2016 Mar; 101(3):266-8. PMID: 26928247; PMCID: PMC4815717.
    42. Valentino LA, Pipe SW, Collins PW, Blanchette VS, Berntorp E, Fischer K, Ewenstein BM, Oh M, Spotts G. Association of peak factor VIII levels and area under the curve with bleeding in patients with haemophilia A on every third day pharmacokinetic-guided prophylaxis. Haemophilia. 2016 Jul; 22(4):514-20. PMID: 26930418.
      View in: PubMed
    43. Blanchette VS, Srivastava A. Definitions in hemophilia: resolved and unresolved issues. Semin Thromb Hemost. 2015 Nov; 41(8):819-25. PMID: 26479892.
      View in: PubMed
    44. Bussel JB, de Miguel PG, Despotovic JM, Grainger JD, Sevilla J, Blanchette VS, Krishnamurti L, Connor P, David M, Boayue KB, Matthews DC, Lambert MP, Marcello LM, Iyengar M, Chan GW, Chagin KD, Theodore D, Bailey CK, Bakshi KK. Eltrombopag for the treatment of children with persistent and chronic immune thrombocytopenia (PETIT): a randomised, multicentre, placebo-controlled study. Lancet Haematol. 2015 Aug; 2(8):e315-25. PMID: 26688484.
      View in: PubMed
    45. Langley AR, Stain AM, Chan A, McLimont M, Chait S, Wu J, Poon MC, Card R, Israels SJ, Laferriere N, Klaassen RJ, Rivard GE, Cloutier S, Hawes S, Feldman B, Blanchette V. Experience with central venous access devices (CVADs) in the Canadian hemophilia primary prophylaxis study (CHPS). Haemophilia. 2015 Jul; 21(4):469-76. PMID: 26104147.
      View in: PubMed
    46. van den Berg HM, Feldman BM, Fischer K, Blanchette V, Poonnoose P, Srivastava A. Assessments of outcome in haemophilia - what is the added value of QoL tools? Haemophilia. 2015 Jul; 21(4):430-5. PMID: 26032397.
      View in: PubMed
    47. Keshava SN, Gibikote SV, Mohanta A, Poonnoose P, Rayner T, Hilliard P, Lakshmi KM, Moineddin R, Ignas D, Srivastava A, Blanchette V, Doria AS. Ultrasound and magnetic resonance imaging of healthy paediatric ankles and knees: a baseline for comparison with haemophilic joints. Haemophilia. 2015 May; 21(3):e210-22. PMID: 25736388.
      View in: PubMed
    48. Doria AS, Keshava SN, Mohanta A, Jarrin J, Blanchette V, Srivastava A, Moineddin R, Kavitha ML, Hilliard P, Poonnoose P, Gibikote S. Diagnostic accuracy of ultrasound for assessment of hemophilic arthropathy: MRI correlation. AJR Am J Roentgenol. 2015 Mar; 204(3):W336-47. PMID: 25714320.
      View in: PubMed
    49. Adler E, Alexis C, Ali Z, Allen U, Bartels U, Bick C, Bird-Compton J, Bodkyn C, Boyle R, De Young S, Fleming-Carroll B, Gupta S, Ingram-Martin P, Irwin M, Kirby-Allen M, McLean-Salmon S, Mihelcic P, Richards-Dawson MA, Reece-Mills M, Shaikh F, Sinquee-Brown C, Thame M, Weitzman S, Wharfe G, Blanchette V. Bridging the Distance in the Caribbean: Telemedicine as a means to build capacity for care in paediatric cancer and blood disorders. Stud Health Technol Inform. 2015; 209:1-8. PMID: 25980698.
      View in: PubMed
    50. McCusker PJ, Fischer K, Holzhauer S, Meunier S, Altisent C, Grainger JD, Blanchette VS, Burke TA, Wakefield C, Young NL. International cross-cultural validation study of the Canadian haemophilia outcomes: kids' life assessment tool. Haemophilia. 2015 May; 21(3):351-7. PMID: 25471939.
      View in: PubMed
    51. Breakey VR, Ignas DM, Warias AV, White M, Blanchette VS, Stinson JN. A pilot randomized control trial to evaluate the feasibility of an Internet-based self-management and transitional care program for youth with haemophilia. Haemophilia. 2014 Nov; 20(6):784-93. PMID: 25311370.
      View in: PubMed
    52. Wu R, Zhang J, Sun J, Zhou M, Wu JS, Li N, Li X, Luke KH, Poon MC, Blanchette VS, Young NL. Validation of the Chinese version of the Canadian Haemophilia Outcomes-Kids' Life Assessment Tool (the CHO-KLAT). Haemophilia. 2014 Nov; 20(6):794-9. PMID: 25273150.
      View in: PubMed
    53. Beck CE, Boydell KM, Stasiulis E, Blanchette VS, Llewellyn-Thomas H, Birken CS, Breakey VR, Parkin PC. Shared decision making in the management of children with newly diagnosed immune thrombocytopenia. J Pediatr Hematol Oncol. 2014 Oct; 36(7):559-65. PMID: 24577546.
      View in: PubMed
    54. Blanchette VS, Key NS, Ljung LR, Manco-Johnson MJ, van den Berg HM, Srivastava A. Definitions in hemophilia: communication from the SSC of the ISTH. J Thromb Haemost. 2014 Nov; 12(11):1935-9. PMID: 25059285.
      View in: PubMed
    55. Abrahamyan L, Willan AR, Beyene J, Mclimont M, Blanchette V, Feldman BM. Using value-of-information methods when the disease is rare and the treatment is expensive--the example of hemophilia A. J Gen Intern Med. 2014 Aug; 29 Suppl 3:S767-73. PMID: 25029970; PMCID: PMC4124117.
    56. Blanchette VS, O'Mahony B, McJames L, Mahlangu JN. Assessment of outcomes. Haemophilia. 2014 May; 20 Suppl 4:114-20. PMID: 24762286.
      View in: PubMed
    57. Doria AS, Zhang N, Lundin B, Hilliard P, Man C, Weiss R, Detzler G, Blanchette V, Moineddin R, Eckstein F, Sussman MS. Quantitative versus semiquantitative MR imaging of cartilage in blood-induced arthritic ankles: preliminary findings. Pediatr Radiol. 2014 May; 44(5):576-86. PMID: 24522564.
      View in: PubMed
    58. Wang H, Bang KW, Blanchette VS, Nurden AT, Rand ML. Phosphatidylserine exposure, microparticle formation and mitochondrial depolarisation in Glanzmann thrombasthenia platelets. Thromb Haemost. 2014 Jun; 111(6):1184-6. PMID: 24477274.
      View in: PubMed
    59. Shapiro AD, Neufeld EJ, Blanchette V, Salaj P, Gut RZ, Cooper DL. Safety of recombinant activated factor VII (rFVIIa) in patients with congenital haemophilia with inhibitors: overall rFVIIa exposure and intervals following high (>240 µg kg?¹) rFVIIa doses across clinical trials and registries. Haemophilia. 2014 Jan; 20(1):e23-31. PMID: 24354484.
      View in: PubMed
    60. Sun J, Hilliard PE, Feldman BM, Zourikian N, Chen L, Blanchette VS, Luke KH, Poon MC. Chinese Hemophilia Joint Health Score 2.1 reliability study. Haemophilia. 2014 May; 20(3):435-40. PMID: 24330460.
      View in: PubMed
    61. Chen L, Sun J, Hilliard P, Zourikian N, Hang M, Blanchette V, Poon MC, Luke K. 'Train-the-Trainer': an effective and successful model to accelerate training and improve physiotherapy services for persons with haemophilia in China. Haemophilia. 2014 May; 20(3):441-5. PMID: 24251688.
      View in: PubMed
    62. Klaassen RJ, Barrowman N, Merelles-Pulcini M, Vichinsky EP, Sweeters N, Kirby-Allen M, Neufeld EJ, Kwiatkowski JL, Wu J, Vickars L, Blanchette VS, Forgie M, Yamashita R, Wong-Rieger D, Young NL. Validation and reliability of a disease-specific quality of life measure (the TranQol) in adults and children with thalassaemia major. Br J Haematol. 2014 Feb; 164(3):431-7. PMID: 24180641.
      View in: PubMed
    63. Breakey VR, Warias AV, Ignas DM, White M, Blanchette VS, Stinson JN. The value of usability testing for Internet-based adolescent self-management interventions: "Managing Hemophilia Online". BMC Med Inform Decis Mak. 2013 Oct 04; 13:113. PMID: 24094082; PMCID: PMC3856537.
    64. Grainger JD, Young NL, Blanchette VS, Klaassen RJ. Quality of life in immune thrombocytopenia following treatment. Arch Dis Child. 2013 Nov; 98(11):895-7. PMID: 23956257.
      View in: PubMed
    65. Boonyawat B, Dhanraj S, Al Abbas F, Zlateska B, Grunenbaum E, Roifman CM, Steele L, Meyn S, Blanchette V, Scherer SW, Swierczek S, Prchal J, Zhu Q, Torgerson TR, Ochs HD, Dror Y. Combined de-novo mutation and non-random X-chromosome inactivation causing Wiskott-Aldrich syndrome in a female with thrombocytopenia. J Clin Immunol. 2013 Oct; 33(7):1150-5. PMID: 23943155.
      View in: PubMed
    66. Chan MW, Leckie A, Xavier F, Uleryk E, Tadros S, Blanchette V, Doria AS. A systematic review of MR imaging as a tool for evaluating haemophilic arthropathy in children. Haemophilia. 2013 Nov; 19(6):e324-34. PMID: 23919318.
      View in: PubMed
    67. Villaça PR, Carneiro JD, D'Amico EA, Blanchette V, Brandão LR, Cassis FR, Santos VN, Sandoval EP, Burke TA, Young NL. Process and experience of cross-cultural adaptation of a quality of life measure (CHO-KLAT) for boys with haemophilia in Brazil. Haemophilia. 2013 Nov; 19(6):861-5. PMID: 23786255.
      View in: PubMed
    68. Cassis FR, Carneiro JD, Villaça PR, D'Amico EA, Santos VN, Roy-Charland A, Burke T, Blanchette V, Brandao LR, Young NL. Importance of literacy for self-reported health-related quality of life: a study of boys with haemophilia in Brazil. Haemophilia. 2013 Nov; 19(6):866-9. PMID: 23786300.
      View in: PubMed
    69. Young NL, Wakefield C, Burke TA, Ray R, McCusker PJ, Blanchette V. Updating the Canadian hemophilia outcomes-kids life assessment tool (CHO-KLAT Version2.0). Value Health. 2013 Jul-Aug; 16(5):837-41. PMID: 23947978.
      View in: PubMed
    70. Labarque V, Stain AM, Blanchette V, Kahr WH, Carcao MD. Intracranial haemorrhage in von Willebrand disease: a report on six cases. Haemophilia. 2013 Jul; 19(4):602-6. PMID: 23556472.
      View in: PubMed
    71. Neunert CE, Buchanan GR, Imbach P, Bolton-Maggs PH, Bennett CM, Neufeld E, Vesely SK, Adix L, Blanchette VS, Kühne T. Bleeding manifestations and management of children with persistent and chronic immune thrombocytopenia: data from the Intercontinental Cooperative ITP Study Group (ICIS). Blood. 2013 May 30; 121(22):4457-62. PMID: 23550040.
      View in: PubMed
    72. Bowman M, Tuttle A, Notley C, Brown C, Tinlin S, Deforest M, Leggo J, Blanchette VS, Lillicrap D, James P. The genetics of Canadian type 3 von Willebrand disease: further evidence for co-dominant inheritance of mutant alleles. J Thromb Haemost. 2013 Mar; 11(3):512-20. PMID: 23311757; PMCID: PMC3904644.
    73. Hilliard P, Zourikian N, Blanchette V, Chan A, Elliott B, Israels SJ, Nilson J, Poon MC, Laferriere N, Van Neste C, Jarock C, Wu J, McLimont M, Feldman B. Musculoskeletal health of subjects with hemophilia A treated with tailored prophylaxis: Canadian Hemophilia Primary Prophylaxis (CHPS) Study. J Thromb Haemost. 2013 Mar; 11(3):460-6. PMID: 23301594.
      View in: PubMed
    74. Rodeghiero F, Michel M, Gernsheimer T, Ruggeri M, Blanchette V, Bussel JB, Cines DB, Cooper N, Godeau B, Greinacher A, Imbach P, Khellaf M, Klaassen RJ, Kühne T, Liebman H, Mazzucconi MG, Newland A, Pabinger I, Tosetto A, Stasi R. Standardization of bleeding assessment in immune thrombocytopenia: report from the International Working Group. Blood. 2013 Apr 04; 121(14):2596-606. PMID: 23361904.
      View in: PubMed
    75. Kraft J, Blanchette V, Babyn P, Feldman B, Cloutier S, Israels S, Pai M, Rivard GE, Gomer S, McLimont M, Moineddin R, Doria AS. Magnetic resonance imaging and joint outcomes in boys with severe hemophilia A treated with tailored primary prophylaxis in Canada. J Thromb Haemost. 2012 Dec; 10(12):2494-502. PMID: 23067060.
      View in: PubMed
    76. Teitel J, Belliveau D, Blanchette V, Chan A, Klaassen R, Price V, Ritchie B, Wu J. A Canadian survey of self-infusion practices in persons with haemophilia A. Haemophilia. 2012 Nov; 18(6):e403-5. PMID: 23106946.
      View in: PubMed
    77. Halton JM, Hand J, Byron P, Strother D, Blanchette V. Establishing physician to patient ratios and predicting workforce needs for Canadian pediatric hematology-oncology programs. Pediatr Blood Cancer. 2013 Apr; 60(4):564-9. PMID: 23042753.
      View in: PubMed
    78. Wu R, Zhang J, Luke KH, Wu X, Burke T, Tang L, Poon MC, Li X, Zhou M, Sun J, Hang M, Blanchette V, Young NL. Cross-cultural adaptation of the CHO-KLAT for boys with hemophilia in rural and urban China. Health Qual Life Outcomes. 2012 Sep 15; 10:112. PMID: 22978454; PMCID: PMC3499387.
    79. Young G, Auerswald G, Jimenez-Yuste V, Lambert T, Morfini M, Santagostino E, Blanchette V. PRO-PACT: retrospective observational study on the prophylactic use of recombinant factor VIIa in hemophilia patients with inhibitors. Thromb Res. 2012 Dec; 130(6):864-70. PMID: 22964026.
      View in: PubMed
    80. Klaassen RJ, Blanchette V, Burke TA, Wakefield C, Grainger JD, Gaedicke G, Riedlinger A, Dufort G, Citrin E, Reguerre Y, Pellier I, Curtis C, Young NL. Quality of life in childhood immune thrombocytopenia: international validation of the kids' ITP tools. Pediatr Blood Cancer. 2013 Jan; 60(1):95-100. PMID: 22848040.
      View in: PubMed
    81. Lundin B, Manco-Johnson ML, Ignas DM, Moineddin R, Blanchette VS, Dunn AL, Gibikote SV, Keshava SN, Ljung R, Manco-Johnson MJ, Miller SF, Rivard GE, Doria AS. An MRI scale for assessment of haemophilic arthropathy from the International Prophylaxis Study Group. Haemophilia. 2012 Nov; 18(6):962-70. PMID: 22765835.
      View in: PubMed
    82. Dimichele DM, Blanchette V, Berntorp E. Clinical trial design in haemophilia. Haemophilia. 2012 Jul; 18 Suppl 4:18-23. PMID: 22726077.
      View in: PubMed
    83. Breakey VR, Blanchette VS. Childhood immune thrombocytopenia: a changing therapeutic landscape. Semin Thromb Hemost. 2011 Oct; 37(7):745-55. PMID: 22187397.
      View in: PubMed
    84. Young NL, St-Louis J, Burke T, Hershon L, Blanchette V. Cross-cultural validation of the CHO-KLAT and HAEMO-QoL-A in Canadian French. Haemophilia. 2012 May; 18(3):353-7. PMID: 22103664.
      View in: PubMed
    85. Björkman S, Oh M, Spotts G, Schroth P, Fritsch S, Ewenstein BM, Casey K, Fischer K, Blanchette VS, Collins PW. Population pharmacokinetics of recombinant factor VIII: the relationships of pharmacokinetics to age and body weight. Blood. 2012 Jan 12; 119(2):612-8. PMID: 22042695.
      View in: PubMed
    86. Miles BS, Anderson P, Agostino A, Golomb MR, Achonu C, Blanchette V, Feldman BM, McLimont M, Revel-Vilk S, Stain A, Barnes MA. Effect of intracranial bleeds on the neurocognitive, academic, behavioural and adaptive functioning of boys with haemophilia. Haemophilia. 2012 Mar; 18(2):229-34. PMID: 21910786.
      View in: PubMed
    87. Klaassen RJ, Mathias SD, Buchanan G, Bussel J, Deuson R, Young NL, Collier A, Bomgaars L, Blanchette V. Pilot study of the effect of romiplostim on child health-related quality of life (HRQoL) and parental burden in immune thrombocytopenia (ITP). Pediatr Blood Cancer. 2012 Mar; 58(3):395-8. PMID: 21910213.
      View in: PubMed
    88. Robertson JD, Yenson PR, Rand ML, Blanchette VS, Carcao MD, Notley C, Lillicrap D, James PD. Expanded phenotype-genotype correlations in a pediatric population with type 1 von Willebrand disease. J Thromb Haemost. 2011 Sep; 9(9):1752-60. PMID: 21711445.
      View in: PubMed
    89. Sterling L, Nyhof-Young J, Blanchette VS, Breakey VR. Exploring internet needs and use among adolescents with haemophilia: a website development project. Haemophilia. 2012 Mar; 18(2):216-21. PMID: 21797947.
      View in: PubMed
    90. Groen W, van der Net J, Bos K, Abad A, Bergstrom BM, Blanchette VS, Feldman BM, Funk S, Helders P, Hilliard P, Manco-Johnson M, Petrini P, Zourikian N, Fischer K. Joint health and functional ability in children with haemophilia who receive intensive replacement therapy. Haemophilia. 2011 Sep; 17(5):783-90. PMID: 21790897.
      View in: PubMed
    91. Grace RF, Bennett CM, Ritchey AK, Jeng M, Thornburg CD, Lambert MP, Neier M, Recht M, Kumar M, Blanchette V, Klaassen RJ, Buchanan GR, Kurth MH, Nugent DJ, Thompson AA, Stine K, Kalish LA, Neufeld EJ. Response to steroids predicts response to rituximab in pediatric chronic immune thrombocytopenia. Pediatr Blood Cancer. 2012 Feb; 58(2):221-5. PMID: 21674758; PMCID: PMC3863944.
    92. Hang MX, Blanchette VS, Pullenayegum E, McLimont M, Feldman BM. Age at first joint bleed and bleeding severity in boys with severe hemophilia A: Canadian Hemophilia Primary Prophylaxis Study. J Thromb Haemost. 2011 May; 9(5):1067-9. PMID: 21320278.
      View in: PubMed
    93. Bussel JB, Buchanan GR, Nugent DJ, Gnarra DJ, Bomgaars LR, Blanchette VS, Wang YM, Nie K, Jun S. A randomized, double-blind study of romiplostim to determine its safety and efficacy in children with immune thrombocytopenia. Blood. 2011 Jul 07; 118(1):28-36. PMID: 21502541.
      View in: PubMed
    94. Revel-Vilk S, Komvilaisak P, Blanchette V, Stain AM, Floros G, Cochrane A, Blanchette C, Hang M, Roberts EA, Ling SC. The changing face of hepatitis in boys with haemophilia associated with increased prevalence of obesity. Haemophilia. 2011 Jul; 17(4):689-94. PMID: 21418443.
      View in: PubMed
    95. Young G, Auerswald G, Jimenez-Yuste V, Konkle BA, Lambert T, Morfini M, Santagostino E, Blanchette V. When should prophylaxis therapy in inhibitor patients be considered? Haemophilia. 2011 Sep; 17(5):e849-57. PMID: 21418444.
      View in: PubMed
    96. Fischer K, Collins P, Björkman S, Blanchette V, Oh M, Fritsch S, Schroth P, Spotts G, Ewenstein B. Trends in bleeding patterns during prophylaxis for severe haemophilia: observations from a series of prospective clinical trials. Haemophilia. 2011 May; 17(3):433-8. PMID: 21299740.
      View in: PubMed
    97. Israels SJ, Kahr WH, Blanchette VS, Luban NL, Rivard GE, Rand ML. Platelet disorders in children: A diagnostic approach. Pediatr Blood Cancer. 2011 Jun; 56(6):975-83. PMID: 21294245.
      View in: PubMed
    98. Feldman BM, Funk SM, Bergstrom BM, Zourikian N, Hilliard P, van der Net J, Engelbert R, Petrini P, van den Berg HM, Manco-Johnson MJ, Rivard GE, Abad A, Blanchette VS. Validation of a new pediatric joint scoring system from the International Hemophilia Prophylaxis Study Group: validity of the hemophilia joint health score. Arthritis Care Res (Hoboken). 2011 Feb; 63(2):223-30. PMID: 20862683.
      View in: PubMed
    99. Breakey VR, Blanchette VS, Bolton-Maggs PH. Towards comprehensive care in transition for young people with haemophilia. Haemophilia. 2010 Nov; 16(6):848-57. PMID: 20491954.
      View in: PubMed
    100. Collins PW, Fischer K, Morfini M, Blanchette VS, Björkman S. Implications of coagulation factor VIII and IX pharmacokinetics in the prophylactic treatment of haemophilia. Haemophilia. 2011 Jan; 17(1):2-10. PMID: 20731726.
      View in: PubMed
    101. Rand ML, Wang H, Bang KW, Teitel JM, Blanchette VS, Freedman J, Nurden AT. Phosphatidylserine exposure and other apoptotic-like events in Bernard-Soulier syndrome platelets. Am J Hematol. 2010 Aug; 85(8):584-92. PMID: 20658588.
      View in: PubMed
    102. Blanchette VS. Prophylaxis in the haemophilia population. Haemophilia. 2010 Jul; 16 Suppl 5:181-8. PMID: 20590879.
      View in: PubMed
    103. Blanchette VS, Manco-Johnson MJ. Meeting unmet needs in inhibitor patients. Haemophilia. 2010 May; 16 Suppl 3:46-51. PMID: 20586802.
      View in: PubMed
    104. Björkman S, Blanchette VS, Fischer K, Oh M, Spotts G, Schroth P, Fritsch S, Patrone L, Ewenstein BM, Collins PW. Comparative pharmacokinetics of plasma- and albumin-free recombinant factor VIII in children and adults: the influence of blood sampling schedule on observed age-related differences and implications for dose tailoring. J Thromb Haemost. 2010 Apr; 8(4):730-6. PMID: 20398185.
      View in: PubMed
    105. Biss TT, Blanchette VS, Clark DS, Wakefield CD, James PD, Rand ML. Use of a quantitative pediatric bleeding questionnaire to assess mucocutaneous bleeding symptoms in children with a platelet function disorder. J Thromb Haemost. 2010 Jun; 8(6):1416-9. PMID: 20236392.
      View in: PubMed
    106. Biss TT, Blanchette VS, Clark DS, Bowman M, Wakefield CD, Silva M, Lillicrap D, James PD, Rand ML. Quantitation of bleeding symptoms in children with von Willebrand disease: use of a standardized pediatric bleeding questionnaire. J Thromb Haemost. 2010 May; 8(5):950-6. PMID: 20136710.
      View in: PubMed
    107. Blanchette V, Bolton-Maggs P. Childhood immune thrombocytopenic purpura: diagnosis and management. Hematol Oncol Clin North Am. 2010 Feb; 24(1):249-73. PMID: 20113906.
      View in: PubMed
    108. Kahr WH, Savoia A, Pluthero FG, Li L, Christensen H, De Rocco D, Traivaree C, Butchart SE, Curtin J, Stollar EJ, Forman-Kay JD, Blanchette VS. Megakaryocyte and platelet abnormalities in a patient with a W33C mutation in the conserved SH3-like domain of myosin heavy chain IIA. Thromb Haemost. 2009 Dec; 102(6):1241-50. PMID: 19967157.
      View in: PubMed
    109. Collins PW, Björkman S, Fischer K, Blanchette V, Oh M, Schroth P, Fritsch S, Casey K, Spotts G, Ewenstein BM. Factor VIII requirement to maintain a target plasma level in the prophylactic treatment of severe hemophilia A: influences of variance in pharmacokinetics and treatment regimens. J Thromb Haemost. 2010 Feb; 8(2):269-75. PMID: 19943875.
      View in: PubMed
    110. Ryan C, Price V, John P, Mahant S, Baruchel S, Brandão L, Blanchette V, Pope E, Weinstein M. Kasabach-Merritt phenomenon: a single centre experience. Eur J Haematol. 2010 Feb 01; 84(2):97-104. PMID: 19889011.
      View in: PubMed
    111. Price VE, Klaassen RJ, Bolton-Maggs PH, Grainger JD, Curtis C, Wakefield C, Dufort G, Riedlinger A, Soltner C, Blanchette VS, Young NL. Measuring disease-specific quality of life in rare populations: a practical approach to cross-cultural translation. Health Qual Life Outcomes. 2009 Oct 23; 7:92. PMID: 19852803; PMCID: PMC2773763.
    112. Provan D, Stasi R, Newland AC, Blanchette VS, Bolton-Maggs P, Bussel JB, Chong BH, Cines DB, Gernsheimer TB, Godeau B, Grainger J, Greer I, Hunt BJ, Imbach PA, Lyons G, McMillan R, Rodeghiero F, Sanz MA, Tarantino M, Watson S, Young J, Kuter DJ. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood. 2010 Jan 14; 115(2):168-86. PMID: 19846889.
      View in: PubMed
    113. Neunert CE, Buchanan GR, Blanchette V, Barnard D, Young NL, Curtis C, Klaassen RJ. Relationships among bleeding severity, health-related quality of life, and platelet count in children with immune thrombocytopenic purpura. Pediatr Blood Cancer. 2009 Oct; 53(4):652-4. PMID: 19492316.
      View in: PubMed
    114. Revel-Vilk S, Blanchette VS, Schmugge M, Clark DS, Lillicrap D, Rand ML. In vitro and in vivo stability of diluted recombinant factor VIII for continuous infusion use in haemophilia A. Haemophilia. 2010 Jan; 16(1):72-9. PMID: 19765092.
      View in: PubMed
    115. Valentino LA, Carcao M, Mathew P, Leissinger CA, Berntorp E, Blanchette V, Escuriola-Ettingshausen C, Ewenstein B, Ewing N, Gringeri A, Hoots WK, Negrier C. The application of bypassing-agent prophylaxis in haemophilia A patients with inhibitors: a meeting report. Haemophilia. 2009 Jul; 15(4):959-65. PMID: 19320750.
      View in: PubMed
    116. Steele M, Cochrane A, Wakefield C, Stain AM, Ling S, Blanchette V, Gold R, Ford-Jones L. Hepatitis A and B immunization for individuals with inherited bleeding disorders. Haemophilia. 2009 Mar; 15(2):437-47. PMID: 19335752.
      View in: PubMed
    117. Blanchette V, Coppes MJ. Routine bleeding history and laboratory tests in children presenting with a renal mass. Pediatr Blood Cancer. 2009 Mar; 52(3):314-5. PMID: 19061220.
      View in: PubMed
    118. Collins PW, Blanchette VS, Fischer K, Björkman S, Oh M, Fritsch S, Schroth P, Spotts G, Astermark J, Ewenstein B. Break-through bleeding in relation to predicted factor VIII levels in patients receiving prophylactic treatment for severe hemophilia A. J Thromb Haemost. 2009 Mar; 7(3):413-20. PMID: 19143924.
      View in: PubMed
    119. Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D, Arnold DM, Bussel JB, Cines DB, Chong BH, Cooper N, Godeau B, Lechner K, Mazzucconi MG, McMillan R, Sanz MA, Imbach P, Blanchette V, Kühne T, Ruggeri M, George JN. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood. 2009 Mar 12; 113(11):2386-93. PMID: 19005182.
      View in: PubMed
    120. Morinis J, Dutta S, Blanchette V, Butchart S, Langer JC. Laparoscopic partial vs total splenectomy in children with hereditary spherocytosis. J Pediatr Surg. 2008 Sep; 43(9):1649-52. PMID: 18779001.
      View in: PubMed
    121. Neunert CE, Buchanan GR, Imbach P, Bolton-Maggs PH, Bennett CM, Neufeld EJ, Vesely SK, Adix L, Blanchette VS, Kühne T. Severe hemorrhage in children with newly diagnosed immune thrombocytopenic purpura. Blood. 2008 Nov 15; 112(10):4003-8. PMID: 18698007; PMCID: PMC2581983.
    122. Biss TT, Chan AK, Blanchette VS, Iwenofu LN, McLimont M, Carcao MD. The use of prophylaxis in 2663 children and adults with haemophilia: results of the 2006 Canadian national haemophilia prophylaxis survey. Haemophilia. 2008 Sep; 14(5):923-30. PMID: 18637844.
      View in: PubMed
    123. Feldman BM, Funk S, Lundin B, Doria AS, Ljung R, Blanchette V. Musculoskeletal measurement tools from the International Prophylaxis Study Group (IPSG). Haemophilia. 2008 Jul; 14 Suppl 3:162-9. PMID: 18510537.
      View in: PubMed
    124. Fischer K, Valentino L, Ljung R, Blanchette V. Prophylaxis for severe haemophilia: clinical challenges in the absence as well as in the presence of inhibitors. Haemophilia. 2008 Jul; 14 Suppl 3:196-201. PMID: 18510542.
      View in: PubMed
    125. Blanchette VS, Shapiro AD, Liesner RJ, Hernández Navarro F, Warrier I, Schroth PC, Spotts G, Ewenstein BM. Plasma and albumin-free recombinant factor VIII: pharmacokinetics, efficacy and safety in previously treated pediatric patients. J Thromb Haemost. 2008 Aug; 6(8):1319-26. PMID: 18503631.
      View in: PubMed
    126. Risebrough N, Oh P, Blanchette V, Curtin J, Hitzler J, Feldman BM. Cost-utility analysis of Canadian tailored prophylaxis, primary prophylaxis and on-demand therapy in young children with severe haemophilia A. Haemophilia. 2008 Jul; 14(4):743-52. PMID: 18422610.
      View in: PubMed
    127. Blanchette V, Bolton-Maggs P. Childhood immune thrombocytopenic purpura: diagnosis and management. Pediatr Clin North Am. 2008 Apr; 55(2):393-420, ix. PMID: 18381093.
      View in: PubMed
    128. Finkelstein Y, Schechter T, Garcia-Bournissen F, Kirby M, Nurmohamed L, Juurlink DN, Blanchette V, Koren G. Is morphine exposure associated with acute chest syndrome in children with vaso-occlusive crisis of sickle cell disease? A 6-year case-crossover study. Clin Ther. 2007 Dec; 29(12):2738-43. PMID: 18201591.
      View in: PubMed
    129. Kühne T, Blanchette V, Buchanan GR, Ramenghi U, Donato H, Tamminga RY, Rischewski J, Berchtold W, Imbach P. Splenectomy in children with idiopathic thrombocytopenic purpura: A prospective study of 134 children from the Intercontinental Childhood ITP Study Group. Pediatr Blood Cancer. 2007 Nov; 49(6):829-34. PMID: 17171689.
      View in: PubMed
    130. Feldman BM, Aledort L, Bullinger M, Delaney FM, Doria AS, Funk S, Giangrande P, Lundin B, Manco-Johnson M, Miners A, Scriba PC, Srivastava A, Schramm W, Blanchette VS. The economics of haemophilia prophylaxis: governmental and insurer perspectives. Proceedings of the Second International Prophylaxis Study Group (IPSG) symposium. Haemophilia. 2007 Nov; 13(6):745-9. PMID: 17850325.
      View in: PubMed
    131. Traivaree C, Blanchette V, Armstrong D, Floros G, Stain AM, Carcao MD. Intracranial bleeding in haemophilia beyond the neonatal period--the role of CT imaging in suspected intracranial bleeding. Haemophilia. 2007 Sep; 13(5):552-9. PMID: 17880443.
      View in: PubMed
    132. Price VE, Blanchette VS, Ford-Jones EL. The prevention and management of infections in children with asplenia or hyposplenia. Infect Dis Clin North Am. 2007 Sep; 21(3):697-710, viii-ix. PMID: 17826619.
      View in: PubMed
    133. Klaassen RJ, Blanchette VS, Barnard D, Wakefield CD, Curtis C, Bradley CS, Neufeld EJ, Buchanan GR, Silva MP, Chan AK, Young NL. Validity, reliability, and responsiveness of a new measure of health-related quality of life in children with immune thrombocytopenic purpura: the Kids' ITP Tools. J Pediatr. 2007 May; 150(5):510-5, 515.e1. PMID: 17452226.
      View in: PubMed
    134. Anderson D, Ali K, Blanchette V, Brouwers M, Couban S, Radmoor P, Huebsch L, Hume H, McLeod A, Meyer R, Moltzan C, Nahirniak S, Nantel S, Pineo G, Rock G. Guidelines on the use of intravenous immune globulin for hematologic conditions. Transfus Med Rev. 2007 Apr; 21(2 Suppl 1):S9-56. PMID: 17397769.
      View in: PubMed
    135. Barnes C, Blanchette V, Lillicrap D, Mann K, Stain AM, Leggo J, Hilliard P, Carcao M. Different clinical phenotype in triplets with haemophilia A. Haemophilia. 2007 Mar; 13(2):202-5. PMID: 17286775.
      View in: PubMed
    136. Belletrutti M, Ali K, Barnard D, Blanchette V, Chan A, David M, Luke B, Price V, Ritchie B, Wu J. Chronic immune thrombocytopenic purpura in children: a survey of the canadian experience. J Pediatr Hematol Oncol. 2007 Feb; 29(2):95-100. PMID: 17279005.
      View in: PubMed
    137. Ota S, Mclimont M, Carcao MD, Blanchette VS, Graham N, Paradis E, Feldman BM. Definitions for haemophilia prophylaxis and its outcomes: the Canadian consensus study. Haemophilia. 2007 Jan; 13(1):12-20. PMID: 17212719.
      View in: PubMed
    138. Schmugge M, Bang KW, Blanchette VS, Albisetti M, Connolly BL, Freedman J, Rand ML. Platelet activation and von Willebrand factor binding to platelets in newborn infants with central venous lines. Acta Haematol. 2007; 117(3):145-8. PMID: 17159336.
      View in: PubMed
    139. Berntorp E, Shapiro A, Astermark J, Blanchette VS, Collins PW, Dimichele D, Escuriola C, Hay CR, Hoots WK, Leissinger CA, Negrier C, Oldenburg J, Peerlinck K, Reding MT, Hart C. Inhibitor treatment in haemophilias A and B: summary statement for the 2006 international consensus conference. Haemophilia. 2006 Dec; 12 Suppl 6:1-7. PMID: 17123387.
      View in: PubMed
    140. Komvilaisak P, Connolly B, Naqvi A, Blanchette V. Overview of the use of implantable venous access devices in the management of children with inherited bleeding disorders. Haemophilia. 2006 Dec; 12 Suppl 6:87-93. PMID: 17123400.
      View in: PubMed
    141. Bradley CS, Bullinger M, McCusker PJ, Wakefield CD, Blanchette VS, Young NL. Comparing two measures of quality of life for children with haemophilia: the CHO-KLAT and the Haemo-QoL. Haemophilia. 2006 Nov; 12(6):643-53. PMID: 17083516.
      View in: PubMed
    142. Dutta S, Price VE, Blanchette V, Langer JC. A laparoscopic approach to partial splenectomy for children with hereditary spherocytosis. Surg Endosc. 2006 Nov; 20(11):1719-24. PMID: 17024531.
      View in: PubMed
    143. Young NL, Bradley CS, Wakefield CD, Barnard D, Blanchette VS, McCusker PJ. How well does the Canadian Haemophilia Outcomes-Kids' Life Assessment Tool (CHO-KLAT) measure the quality of life of boys with haemophilia? Pediatr Blood Cancer. 2006 Sep; 47(3):305-11. PMID: 16206209.
      View in: PubMed
    144. Mannucci PM, Abshire T, Dimichele D, Santagostino E, Blanchette V. Inhibitor development, immune tolerance and prophylaxis in haemophilia A--the need for an evidence-based approach. Haemophilia. 2006 Jul; 12(4):429-34. PMID: 16834746.
      View in: PubMed
    145. Van den Berg HM, Dunn A, Fischer K, Blanchette VS. Prevention and treatment of musculoskeletal disease in the haemophilia population: role of prophylaxis and synovectomy. Haemophilia. 2006 Jul; 12 Suppl 3:159-68. PMID: 16684012.
      View in: PubMed
    146. Feldman BM, Pai M, Rivard GE, Israels S, Poon MC, Demers C, Robinson S, Luke KH, Wu JK, Gill K, Lillicrap D, Babyn P, McLimont M, Blanchette VS. Tailored prophylaxis in severe hemophilia A: interim results from the first 5 years of the Canadian Hemophilia Primary Prophylaxis Study. J Thromb Haemost. 2006 Jun; 4(6):1228-36. PMID: 16706965.
      View in: PubMed
    147. Valentino LA, Santagostino E, Blanchette V, van den Berg M. Managing the pediatric patient and the adolescent/adult transition. Semin Thromb Hemost. 2006 Jun; 32 Suppl 2:28-31. PMID: 16804833.
      View in: PubMed
    148. Price VE, Dutta S, Blanchette VS, Butchart S, Kirby M, Langer JC, Ford-Jones EL. The prevention and treatment of bacterial infections in children with asplenia or hyposplenia: practice considerations at the Hospital for Sick Children, Toronto. Pediatr Blood Cancer. 2006 May 01; 46(5):597-603. PMID: 16333816.
      View in: PubMed
    149. Aledort L, Ljung R, Blanchette V. Are randomized clinical trials the only truth? Not always. J Thromb Haemost. 2006 Mar; 4(3):503-4. PMID: 16460429.
      View in: PubMed
    150. Price V, Barnes C, Canning P, Blanchette V, Greenberg M. Immune thrombocytopenia following successful treatment of cancer in children. Pediatr Blood Cancer. 2006 Mar; 46(3):372-6. PMID: 15700256.
      View in: PubMed
    151. Barnes C, Rivard GE, Poon MC, Teitel J, Pai M, Kern M, Blanchette VS, Carcao M. Canadian multi-institutional survey of immune tolerance therapy (ITT) -- experience with the use of recombinant factor VIII for ITT. Haemophilia. 2006 Jan; 12(1):1-6. PMID: 16409169.
      View in: PubMed
    152. Carcao M, St Louis J, Poon MC, Grunebaum E, Lacroix S, Stain AM, Blanchette VS, Rivard GE. Rituximab for congenital haemophiliacs with inhibitors: a Canadian experience. Haemophilia. 2006 Jan; 12(1):7-18. PMID: 16409170.
      View in: PubMed
    153. Beck CE, Nathan PC, Parkin PC, Blanchette VS, Macarthur C. Corticosteroids versus intravenous immune globulin for the treatment of acute immune thrombocytopenic purpura in children: a systematic review and meta-analysis of randomized controlled trials. J Pediatr. 2005 Oct; 147(4):521-7. PMID: 16227040.
      View in: PubMed
    154. Heemstra HE, Zwaan T, Hemels M, Feldman BM, Blanchette V, Kern M, Einarson TR. Cost of severe haemophilia in Toronto. Haemophilia. 2005 May; 11(3):254-60. PMID: 15876271.
      View in: PubMed
    155. Barnes C, Blanchette V, Canning P, Carcao M. Recombinant FVIIa in the management of intracerebral haemorrhage in severe thrombocytopenia unresponsive to platelet-enhancing treatment. Transfus Med. 2005 Apr; 15(2):145-50. PMID: 15859982.
      View in: PubMed
    156. Feldman BM, Babyn P, Doria AS, Heijnen L, Jacobson J, Kilcoyne R, Lundin B, Manco-Johnson M, McLimont M, Petrini P, Pettersson H, Blanchette VS. Proceedings of the International Haemophilia Prophylaxis Study Group Meeting, November 2003, Montreal, PQ, Canada. Haemophilia. 2005 Jan; 11(1):58-63. PMID: 15660990.
      View in: PubMed
    157. Kern M, Blanchette V, Stain AM, Einarson TR, Feldman BM. Clinical and cost implications of target joints in Canadian boys with severe hemophilia A. J Pediatr. 2004 Nov; 145(5):628-34. PMID: 15520762.
      View in: PubMed
    158. Blanchette P, Rivard G, Israels S, Robinson S, Ali K, Walker I, Stain AM, Blanchette V. A survey of factor prophylaxis in the Canadian haemophilia A population. Haemophilia. 2004 Nov; 10(6):679-83. PMID: 15569161.
      View in: PubMed
    159. Manco-Johnson MJ, Pettersson H, Petrini P, Babyn PS, Bergstrom BM, Bradley CS, Doria AS, Feldman BM, Funk S, Hilliard P, Kilcoyne R, Lundin B, Nuss R, Rivard G, Schoenmakers MA, Van den Berg M, Wiedel J, Zourikian N, Blanchette VS. Physical therapy and imaging outcome measures in a haemophilia population treated with factor prophylaxis: current status and future directions. Haemophilia. 2004 Oct; 10 Suppl 4:88-93. PMID: 15479378.
      View in: PubMed
    160. Blanchette VS, Manco-Johnson M, Santagostino E, Ljung R. Optimizing factor prophylaxis for the haemophilia population: where do we stand? Haemophilia. 2004 Oct; 10 Suppl 4:97-104. PMID: 15479380.
      View in: PubMed
    161. Shapiro AD, Di Paola J, Cohen A, Pasi KJ, Heisel MA, Blanchette VS, Abshire TC, Hoots WK, Lusher JM, Negrier C, Rothschild C, Roth DA. The safety and efficacy of recombinant human blood coagulation factor IX in previously untreated patients with severe or moderately severe hemophilia B. Blood. 2005 Jan 15; 105(2):518-25. PMID: 15383463.
      View in: PubMed
    162. Ewenstein BM, Valentino LA, Journeycake JM, Tarantino MD, Shapiro AD, Blanchette VS, Hoots WK, Buchanan GR, Manco-Johnson MJ, Rivard GE, Miller KL, Geraghty S, Maahs JA, Stuart R, Dunham T, Navickis RJ. Consensus recommendations for use of central venous access devices in haemophilia. Haemophilia. 2004 Sep; 10(5):629-48. PMID: 15357790.
      View in: PubMed
    163. Hedlund-Treutiger I, Revel-Vilk S, Blanchette VS, Curtin JA, Lillicrap D, Rand ML. Reliability and reproducibility of classification of children as "bleeders" versus "non-bleeders" using a questionnaire for significant mucocutaneous bleeding. J Pediatr Hematol Oncol. 2004 Aug; 26(8):488-91. PMID: 15284585.
      View in: PubMed
    164. Price VE, Carcao M, Connolly B, Chait P, Daneman A, Temple M, Stain AM, Sung L, Al-Tralbosi H, Blanchette VS. A prospective, longitudinal study of central venous catheter-related deep venous thrombosis in boys with hemophilia. J Thromb Haemost. 2004 May; 2(5):737-42. PMID: 15099279.
      View in: PubMed
    165. Nurden AT, Breillat C, Jacquelin B, Combrié R, Freedman J, Blanchette VS, Schmugge M, Rand ML. Triple heterozygosity in the integrin alphaIIb subunit in a patient with Glanzmann's thrombasthenia. J Thromb Haemost. 2004 May; 2(5):813-9. PMID: 15099289.
      View in: PubMed
    166. Revel-Vilk S, Golomb MR, Achonu C, Stain AM, Armstrong D, Barnes MA, Anderson P, Logan WJ, Sung L, McNeely M, Blanchette V, Feldman BM. Effect of intracranial bleeds on the health and quality of life of boys with hemophilia. J Pediatr. 2004 Apr; 144(4):490-5. PMID: 15069398.
      View in: PubMed
    167. Bohn RL, Schramm W, Bullinger M, van den Berg M, Blanchette V. Outcome measures in haemophilia: more than just factor levels. Haemophilia. 2004 Mar; 10 Suppl 1:2-8. PMID: 14987243.
      View in: PubMed
    168. Young NL, Bradley CS, Blanchette V, Wakefield CD, Barnard D, Wu JK, McCusker PJ. Development of a health-related quality of life measure for boys with haemophilia: the Canadian Haemophilia Outcomes--Kids Life Assessment Tool (CHO-KLAT). Haemophilia. 2004 Mar; 10 Suppl 1:34-43. PMID: 14987247.
      View in: PubMed
    169. Schmugge M, Dunn MS, Amankwah KS, Blanchette VS, Freedman J, Rand ML. The activity of the von Willebrand factor cleaving protease ADAMTS-13 in newborn infants. J Thromb Haemost. 2004 Feb; 2(2):228-33. PMID: 14995983.
      View in: PubMed
    170. Ewenstein BM, Collins P, Tarantino MD, Negrier C, Blanchette V, Shapiro AD, Baker D, Spotts G, Sensel M, Yi SE, Gomperts ED. Hemophilia therapy innovation: development of an advanced category recombinant factor VIII by a plasma/albumin-free method. Proceedings of a Special Symposium at the XIXth Congress of the International Society on Thrombosis and Haemostasis, July 12-18, 2003, Birmingham, UK. Semin Hematol. 2004 Jan; 41(1 Suppl 2):1-16; discussion 16-8. PMID: 15071785.
      View in: PubMed
    171. Imbach P, Kühne T, Blanchette V. Overview of the State of the Art Expert Meeting of the Intercontinental Childhood ITP Study Group (ICIS). J Pediatr Hematol Oncol. 2003 Dec; 25 Suppl 1:S1-6. PMID: 14668630.
      View in: PubMed
    172. Blanchette VS, Price V. Childhood chronic immune thrombocytopenic purpura: unresolved issues. J Pediatr Hematol Oncol. 2003 Dec; 25 Suppl 1:S28-33. PMID: 14668636.
      View in: PubMed
    173. Goldman RD, Blanchette V, Koren G. Hemophilia during pregnancy. Can Fam Physician. 2003 Dec; 49:1601-3. PMID: 14708924; PMCID: PMC2214172.
    174. Blanchette VS, Carcao M. Childhood acute immune thrombocytopenic purpura: 20 years later. Semin Thromb Hemost. 2003 Dec; 29(6):605-17. PMID: 14719177.
      View in: PubMed
    175. Revel-Vilk S, Schmugge M, Carcao MD, Blanchette P, Rand ML, Blanchette VS. Desmopressin (DDAVP) responsiveness in children with von Willebrand disease. J Pediatr Hematol Oncol. 2003 Nov; 25(11):874-9. PMID: 14608197.
      View in: PubMed
    176. Schmugge M, Revel-Vilk S, Hiraki L, Rand ML, Blanchette VS, Silverman ED. Thrombocytopenia and thromboembolism in pediatric systemic lupus erythematosus. J Pediatr. 2003 Nov; 143(5):666-9. PMID: 14615743.
      View in: PubMed
    177. Freedman J, Rand ML, Russell O, Davis C, Cheatley PL, Blanchette V, Garvey MB. Immunoadsorption may provide a cost-effective approach to management of patients with inhibitors to FVIII. Transfusion. 2003 Nov; 43(11):1508-13. PMID: 14617307.
      View in: PubMed
    178. Carcao MD, Connolly BL, Chait P, Stain AM, Acebes M, Massicotte P, Blanchette VS. Central venous catheter-related thrombosis presenting as superior vena cava syndrome in a haemophilic patient with inhibitors. Haemophilia. 2003 Sep; 9(5):578-83. PMID: 14511297.
      View in: PubMed
    179. Brunner HI, Maker D, Grundland B, Young NL, Blanchette V, Stain AM, Feldman BM. Preference-based measurement of health-related quality of life (HRQL) in children with chronic musculoskeletal disorders (MSKDs). Med Decis Making. 2003 Jul-Aug; 23(4):314-22. PMID: 12926581.
      View in: PubMed
    180. Schmugge M, Rand ML, Bang KW, Mody M, Dunn MS, Amankwah KS, Blanchette VS, Freedman J. The relationship of von Willebrand factor binding to activated platelets from healthy neonates and adults. Pediatr Res. 2003 Oct; 54(4):474-9. PMID: 12815111.
      View in: PubMed
    181. Sharathkumar A, Lillicrap D, Blanchette VS, Kern M, Leggo J, Stain AM, Brooker L, Carcao MD. Intensive exposure to factor VIII is a risk factor for inhibitor development in mild hemophilia A. J Thromb Haemost. 2003 Jun; 1(6):1228-36. PMID: 12871324.
      View in: PubMed
    182. Berntorp E, Astermark J, Björkman S, Blanchette VS, Fischer K, Giangrande PL, Gringeri A, Ljung RC, Manco-Johnson MJ, Morfini M, Kilcoyne RF, Petrini P, Rodriguez-Merchan EC, Schramm W, Shapiro A, van den Berg HM, Hart C. Consensus perspectives on prophylactic therapy for haemophilia: summary statement. Haemophilia. 2003 May; 9 Suppl 1:1-4. PMID: 12709030.
      View in: PubMed
    183. Blanchette VS, McCready M, Achonu C, Abdolell M, Rivard G, Manco-Johnson MJ. A survey of factor prophylaxis in boys with haemophilia followed in North American haemophilia treatment centres. Haemophilia. 2003 May; 9 Suppl 1:19-26; discussion 26. PMID: 12709033.
      View in: PubMed
    184. Manco-Johnson MJ, Blanchette VS. North American prophylaxis studies for persons with severe haemophilia: background, rationale and design. Haemophilia. 2003 May; 9 Suppl 1:44-8; discussion 49. PMID: 12709037.
      View in: PubMed
    185. Vesely SK, Buchanan GR, Adix L, George JN, Cohen AR, Blanchette VS, Kühne T. Self-reported initial management of childhood idiopathic thrombocytopenic purpura: results of a survey of members of the American Society of Pediatric Hematology/Oncology, 2001. J Pediatr Hematol Oncol. 2003 Feb; 25(2):130-3. PMID: 12571464.
      View in: PubMed
    186. Carcao MD, Blanchette VS, Wakefield CD, Stephens D, Ellis J, Matheson K, Denomme GA. Fcgamma receptor IIa and IIIa polymorphisms in childhood immune thrombocytopenic purpura. Br J Haematol. 2003 Jan; 120(1):135-41. PMID: 12492589.
      View in: PubMed
    187. Barnard D, Woloski M, Feeny D, McCusker P, Wu J, David M, Bussel J, Lusher J, Wakefield C, Henriques S, Blanchette V. Development of disease-specific health-related quality-of-life instruments for children with immune thrombocytopenic purpura and their parents. J Pediatr Hematol Oncol. 2003 Jan; 25(1):56-62. PMID: 12544774.
      View in: PubMed
    188. Brown SA, Aledort LM, Astermark J, Berntorp E, van den Berg M, Blanchette V, Donfield S, Gringeri A, Hilgartner M, Kulkarni R, Leissinger C, Negrier C, Nuss R, Petterson H, Petrini P, Poulios N, Schramm W. Unresolved issues in prophylaxis. Haemophilia. 2002 Nov; 8(6):817-21. PMID: 12410654.
      View in: PubMed
    189. Berman J, Young N, Carcao M, Blanchette V, Ipp M. Hospitalization of children with acute immune thrombocytopenic purpura - is it necessary? Paediatr Child Health. 2002 Jul; 7(6):386-9. PMID: 20046330; PMCID: PMC2795686.
    190. Revel-Vilk S, Blanchette VS, Sparling C, Stain AM, Carcao MD. DDAVP challenge tests in boys with mild/moderate haemophilia A. Br J Haematol. 2002 Jun; 117(4):947-51. PMID: 12060135.
      View in: PubMed
    191. Carcao MD, Blanchette VS, Stephens D, He L, Wakefield CD, Butchart S, Christie DJ, Rand ML. Assessment of thrombocytopenic disorders using the Platelet Function Analyzer (PFA-100). Br J Haematol. 2002 Jun; 117(4):961-4. PMID: 12060138.
      View in: PubMed
    192. Cines DB, Blanchette VS. Immune thrombocytopenic purpura. N Engl J Med. 2002 Mar 28; 346(13):995-1008. PMID: 11919310.
      View in: PubMed
    193. Naraine VS, Risebrough NA, Oh P, Blanchette VS, Lee S, Stain AM, Hedden D, Teitel JM, Feldman BM. Health-related quality-of-life treatments for severe haemophilia: utility measurements using the Standard Gamble technique. Haemophilia. 2002 Mar; 8(2):112-20. PMID: 11952846.
      View in: PubMed
    194. Freedman J, Mody M, Lazarus AH, Dewar L, Song S, Blanchette VS, Garvey MB, Ofosu FA. Platelet activation and hypercoagulability following treatment with porcine factor VIII (HYATE:C). Am J Hematol. 2002 Mar; 69(3):192-9. PMID: 11891806.
      View in: PubMed
    195. Semple JW, Allen D, Rutherford M, Woloski M, David M, Wakefield C, Butchart S, Freedman J, Blanchette V. Anti-D (WinRho SD) treatment of children with chronic autoimmune thrombocytopenic purpura stimulates transient cytokine/chemokine production. Am J Hematol. 2002 Mar; 69(3):225-7. PMID: 11891813.
      View in: PubMed
    196. Blanchette V. Childhood chronic immune thrombocytopenic purpura (ITP). Blood Rev. 2002 Mar; 16(1):23-6. PMID: 11913989.
      View in: PubMed
    197. Kühne T, Imbach P, Bolton-Maggs PH, Berchtold W, Blanchette V, Buchanan GR. Newly diagnosed idiopathic thrombocytopenic purpura in childhood: an observational study. Lancet. 2001 Dec 22-29; 358(9299):2122-5. PMID: 11784627.
      View in: PubMed
    198. Klaassen RJ, Doyle JJ, Krahn MD, Blanchette VS, Naglie G. Initial bone marrow aspiration in childhood idiopathic thrombocytopenia: decision analysis. J Pediatr Hematol Oncol. 2001 Nov; 23(8):511-8. PMID: 11878779.
      View in: PubMed
    199. Fouladi M, Herman R, Rolland-Grinton M, Jones-Wallace D, Blanchette V, Calderwood S, Doyle J, Halperin D, Leaker M, Saunders EF, Zipursky A, Freedman MH. Improved survival in severe acquired aplastic anemia of childhood. Bone Marrow Transplant. 2000 Dec; 26(11):1149-56. PMID: 11149724.
      View in: PubMed
    200. Patterson BJ, Freedman J, Blanchette V, Sher G, Pinkerton P, Hannach B, Meharchand J, Lau W, Boyce N, Pinchefsky E, Tasev T, Pinchefsky J, Poon S, Shulman L, MacK P, Thomas K, Blanchette N, Greenspan D, Panzarella T. Effect of premedication guidelines and leukoreduction on the rate of febrile nonhaemolytic platelet transfusion reactions. Transfus Med. 2000 Sep; 10(3):199-206. PMID: 10972914.
      View in: PubMed
    201. Dean JA, Blanchette VS, Carcao MD, Stain AM, Sparling CR, Siekmann J, Turecek PL, Lillicrap D, Rand ML. von Willebrand disease in a pediatric-based population--comparison of type 1 diagnostic criteria and use of the PFA-100 and a von Willebrand factor/collagen-binding assay. Thromb Haemost. 2000 Sep; 84(3):401-9. PMID: 11019962.
      View in: PubMed
    202. Blanchette VS, Johnson J, Rand M. The management of alloimmune neonatal thrombocytopenia. Baillieres Best Pract Res Clin Haematol. 2000 Sep; 13(3):365-90. PMID: 11030040.
      View in: PubMed
    203. Blanchette V, Carcao M. Approach to the investigation and management of immune thrombocytopenic purpura in children. Semin Hematol. 2000 Jul; 37(3):299-314. PMID: 10942224.
      View in: PubMed
    204. Bang KW, Speck ER, Blanchette VS, Freedman J, Semple JW. Unique processing pathways within recipient antigen-presenting cells determine IgG immunity against donor platelet MHC antigens. Blood. 2000 Mar 01; 95(5):1735-42. PMID: 10688832.
      View in: PubMed
    205. Wright JF, Wang H, Hornstein A, Hogarth M, Mody M, Garvey MB, Blanchette V, Rock G, Freedman J. Characterization of platelet glycoproteins and platelet/endothelial cell antibodies in patients with thrombotic thrombocytopenic purpura. Br J Haematol. 1999 Dec; 107(3):546-55. PMID: 10583256.
      View in: PubMed
    206. Dror Y, Blanchette VS. Essential thrombocythaemia in children. Br J Haematol. 1999 Dec; 107(4):691-8. PMID: 10606871.
      View in: PubMed
    207. Dror Y, Zipursky A, Blanchette VS. Essential thrombocythemia in children. J Pediatr Hematol Oncol. 1999 Sep-Oct; 21(5):356-63. PMID: 10524447.
      View in: PubMed
    208. Lazarus AH, Crow AR, Freedman J, Blanchette V, Hannach B. Inhibition of a secondary human alloimmune response via the soluble active component of CD154 (CD40L) in severe combined immune-deficient mice engrafted with human lymphocytes. Transfusion. 1999 Aug; 39(8):818-23. PMID: 10504115.
      View in: PubMed
    209. Chang H, Sher GD, Blanchette VS, Teitel JM. The impact of inhibitors on the cost of clotting factor replacement therapy in Haemophilia A in Canada. Haemophilia. 1999 Jul; 5(4):247-52. PMID: 10469178.
      View in: PubMed
    210. Crow AR, Freedman J, Hannach B, Blanchette V, Lazarus AH. Antibody-mediated inhibition of the human alloimmune response to platelet transfusion in Hu-PBL-SCID mice. Br J Haematol. 1999 Mar; 104(4):919-24. PMID: 10192460.
      View in: PubMed
    211. Semple JW, Speck ER, Cosgrave D, Lazarus AH, Blanchette VS, Freedman J. Extreme leukoreduction of major histocompatibility complex class II positive B cells enhances allogeneic platelet immunity. Blood. 1999 Jan 15; 93(2):713-20. PMID: 9885234.
      View in: PubMed
    212. Chia WK, Blanchette V, Mody M, Wright JF, Freedman J. Characterization of HIV-1-specific antibodies and HIV-1-crossreactive antibodies to platelets in HIV-1-infected haemophiliac patients. Br J Haematol. 1998 Dec; 103(4):1014-22. PMID: 9886313.
      View in: PubMed
    213. Ludwig K, Petric M, Blanchette V, Karmali M. Isolated thrombocytopenic purpura associated with infection due to verocytotoxin (Shiga toxin)-producing Escherichia coli serotype O26:H11. Clin Infect Dis. 1998 Sep; 27(3):660-1. PMID: 9770182.
      View in: PubMed
    214. Blanchette V, Carcao M. Intravenous immunoglobulin G and anti-D as therapeutic interventions in immune thrombocytopenic purpura. Transfus Sci. 1998 Sep; 19(3):279-88. PMID: 10351140.
      View in: PubMed
    215. Lazarus AH, Ellis J, Blanchette V, Freedman J, Sheng-Tanner X. Permeabilization and fixation conditions for intracellular flow cytometric detection of the T-cell receptor zeta chain and other intracellular proteins in lymphocyte subpopulations. Cytometry. 1998 Jul 01; 32(3):206-13. PMID: 9667510.
      View in: PubMed
    216. Saxon BR, Mody M, Blanchette VS, Freedman J. Reticulated platelet counts in the assessment of thrombocytopenic disorders. Acta Paediatr Suppl. 1998 Jun; 424:65-70. PMID: 9736223.
      View in: PubMed
    217. Carcao MD, Zipursky A, Butchart S, Leaker M, Blanchette VS. Short-course oral prednisone therapy in children presenting with acute immune thrombocytopenic purpura (ITP). Acta Paediatr Suppl. 1998 Jun; 424:71-4. PMID: 9736224.
      View in: PubMed
    218. Kühne T, Elinder G, Blanchette VS, Garvey B. Current management issues of childhood and adult immune thrombocytopenic purpura (ITP). Acta Paediatr Suppl. 1998 Jun; 424:75-81. PMID: 9736225.
      View in: PubMed
    219. Freedman J, Garvey MB, Elinder G, Blanchette VS. Directions for research in autoimmune thrombocytopenic purpura (ITP). Acta Paediatr Suppl. 1998 Jun; 424:82-4. PMID: 9736226.
      View in: PubMed
    220. Carcao MD, Blanchette VS, Dean JA, He L, Kern MA, Stain AM, Sparling CR, Stephens D, Ryan G, Freedman J, Rand ML. The Platelet Function Analyzer (PFA-100): a novel in-vitro system for evaluation of primary haemostasis in children. Br J Haematol. 1998 Apr; 101(1):70-3. PMID: 9576184.
      View in: PubMed
    221. Chang H, Mody M, Lazarus AH, Ofosu F, Garvey MB, Blanchette V, Teitel J, Freedman J. Platelet activation induced by porcine factor VIII (Hyate:C). Am J Hematol. 1998 Mar; 57(3):200-5. PMID: 9495369.
      View in: PubMed
    222. Blanchette V, Freedman J, Garvey B. Management of chronic immune thrombocytopenic purpura in children and adults. Semin Hematol. 1998 Jan; 35(1 Suppl 1):36-51. PMID: 9523748.
      View in: PubMed
    223. Rand ML, Carcao MD, Blanchette VS. Use of the PFA-100 in the assessment of primary, platelet-related hemostasis in a pediatric setting. Semin Thromb Hemost. 1998; 24(6):523-9. PMID: 10066147.
      View in: PubMed
    224. Saxon BR, Blanchette VS, Butchart S, Lim-Yin J, Poon AO. Reticulated platelet counts in the diagnosis of acute immune thrombocytopenic purpura. J Pediatr Hematol Oncol. 1998 Jan-Feb; 20(1):44-8. PMID: 9482412.
      View in: PubMed
    225. Lazarus AH, Crow AR, Semple JW, Cosgrave D, Kalovsky EJ, Hannach B, Blanchette V, Freedman J. Induction of a secondary human anti-HLA alloimmune response in severe combined immunodeficient mice engrafted with human lymphocytes. Transfusion. 1997 Nov-Dec; 37(11-12):1192-9. PMID: 9426645.
      View in: PubMed
    226. Westman P, Hashemi-Tavoularis S, Blanchette V, Kekomäki S, Laes M, Porcelijn L, Kekomäki R. Maternal DRB1*1501, DQA1*0102, DQB1*0602 haplotype in fetomaternal alloimmunization against human platelet alloantigen HPA-6b (GPIIIa-Gln489). Tissue Antigens. 1997 Aug; 50(2):113-8. PMID: 9271820.
      View in: PubMed
    227. Blanchette VS, Al-Musa A, Stain AM, Ingram J, Fille RM. Central venous access devices in children with hemophilia: an update. Blood Coagul Fibrinolysis. 1997 Aug; 8 Suppl 1:S11-4. PMID: 9351530.
      View in: PubMed
    228. Blanchette VS. Recombinant factor VIII in hemophilia A: the Canadian experience. Blood Coagul Fibrinolysis. 1997 Aug; 8 Suppl 1:S33-9. PMID: 9351535.
      View in: PubMed
    229. Hume H, Blanchette V, Strauss RG, Levy GJ. A survey of Canadian neonatal blood transfusion practices. Transfus Sci. 1997 Mar; 18(1):71-80. PMID: 10174295.
      View in: PubMed
    230. Johnson JA, Ryan G, al-Musa A, Farkas S, Blanchette VS. Prenatal diagnosis and management of neonatal alloimmune thrombocytopenia. Semin Perinatol. 1997 Feb; 21(1):45-52. PMID: 9190033.
      View in: PubMed
    231. Blanchette VS, Rand ML. Platelet disorders in newborn infants: diagnosis and management. Semin Perinatol. 1997 Feb; 21(1):53-62. PMID: 9190034.
      View in: PubMed
    232. Kühne T, Freedman J, Semple JW, Doyle J, Butchart S, Blanchette VS. Platelet and immune responses to oral cyclic dexamethasone therapy in childhood chronic immune thrombocytopenic purpura. J Pediatr. 1997 Jan; 130(1):17-24. PMID: 9003846.
      View in: PubMed
    233. Kühne T, Ryan G, Blanchette V, Semple JW, Hornstein A, Mody M, Chang W, McWhirter L, Freedman J. Platelet-surface glycoproteins in healthy and preeclamptic mothers and their newborn infants. Pediatr Res. 1996 Dec; 40(6):876-80. PMID: 8947966.
      View in: PubMed
    234. Bang A, Speck ER, Blanchette VS, Freedman J, Semple JW. Recipient humoral immunity against leukoreduced allogeneic platelets is suppressed by aminoguanidine, a selective inhibitor of inducible nitric oxide synthase. Blood. 1996 Oct 15; 88(8):2959-66. PMID: 8874192.
      View in: PubMed
    235. Wright JF, Blanchette VS, Wang H, Arya N, Petric M, Semple JW, Chia WK, Freedman J. Characterization of platelet-reactive antibodies in children with varicella-associated acute immune thrombocytopenic purpura (ITP). Br J Haematol. 1996 Oct; 95(1):145-52. PMID: 8857953.
      View in: PubMed
    236. George JN, Woolf SH, Raskob GE, Wasser JS, Aledort LM, Ballem PJ, Blanchette VS, Bussel JB, Cines DB, Kelton JG, Lichtin AE, McMillan R, Okerbloom JA, Regan DH, Warrier I. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood. 1996 Jul 01; 88(1):3-40. PMID: 8704187.
      View in: PubMed
    237. Rock G, Adamkiewicz T, Blanchette V, Poon A, Sparling C. Acquired von Willebrand factor deficiency during high-dose infusion of recombinant factor VIII. Br J Haematol. 1996 Jun; 93(3):684-7. PMID: 8652394.
      View in: PubMed
    238. Semple JW, Milev Y, Cosgrave D, Mody M, Hornstein A, Blanchette V, Freedman J. Differences in serum cytokine levels in acute and chronic autoimmune thrombocytopenic purpura: relationship to platelet phenotype and antiplatelet T-cell reactivity. Blood. 1996 May 15; 87(10):4245-54. PMID: 8639783.
      View in: PubMed
    239. Blanchette VS, al-Musa A, Stain AM, Filler RM, Ingram J. Central venous access catheters in children with haemophilia. Blood Coagul Fibrinolysis. 1996 Mar; 7 Suppl 1:S39-44. PMID: 8735796.
      View in: PubMed
    240. Berkovitch M, Matsui D, Zipursky A, Blanchette VS, Verjee Z, Giesbrecht E, Saunders EF, Evans WE, Koren G. Hepatotoxicity of 6-mercaptopurine in childhood acute lymphocytic leukemia: pharmacokinetic characteristics. Med Pediatr Oncol. 1996 Feb; 26(2):85-9. PMID: 8531858.
      View in: PubMed
    241. Lazarus AH, Wright JF, Blanchette V, Freedman J. Analysis of platelets by flow cytometry. Transfus Sci. 1995 Dec; 16(4):353-61. PMID: 10159506.
      View in: PubMed
    242. DeCoteau J, Haddad S, Blanchette V, Poon A. Refractoriness to platelet transfusions in children with acute leukemia. J Pediatr Hematol Oncol. 1995 Nov; 17(4):306-10. PMID: 7583385.
      View in: PubMed
    243. Kühne T, Hornstein A, Semple J, Chang W, Blanchette V, Freedman J. Flow cytometric evaluation of platelet activation in blood collected into EDTA vs. Diatube-H, a sodium citrate solution supplemented with theophylline, adenosine, and dipyridamole. Am J Hematol. 1995 Sep; 50(1):40-5. PMID: 7668222.
      View in: PubMed
    244. Semple JW, Speck ER, Milev YP, Blanchette V, Freedman J. Indirect allorecognition of platelets by T helper cells during platelet transfusions correlates with anti-major histocompatibility complex antibody and cytotoxic T lymphocyte formation. Blood. 1995 Jul 15; 86(2):805-12. PMID: 7606011.
      View in: PubMed
    245. Hume H, Blanchette VS. Symposium on neonatal transfusion practices. Transfus Med Rev. 1995 Jul; 9(3):185-6. PMID: 7549230.
      View in: PubMed
    246. Blanchette VS, Kühne T, Hume H, Hellmann J. Platelet transfusion therapy in newborn infants. Transfus Med Rev. 1995 Jul; 9(3):215-30. PMID: 7549233.
      View in: PubMed
    247. Imbach P, Akatsuka J, Blanchette V, Burek-Kozlowska A, Bussel J, Gaedicke G, Gianella-Borradori A, Gugler E, Hirt A, Imholz B, et al. Immunthrombocytopenic purpura as a model for pathogenesis and treatment of autoimmunity. Eur J Pediatr. 1995; 154(9 Suppl 4):S60-4. PMID: 8529713.
      View in: PubMed
    248. Blanchette V, Imbach P, Andrew M, Adams M, McMillan J, Wang E, Milner R, Ali K, Barnard D, Bernstein M, et al. Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura. Lancet. 1994 Sep 10; 344(8924):703-7. PMID: 7915773.
      View in: PubMed
    249. Calderwood S, Romeyer F, Blanchette V, Chan H, Doyle J, Greenberg M, Lorenzana A, Malkin D, Saunders F, Weitzman S, et al. Concurrent RhGM-CSF does not offset myelosuppression from intensive chemotherapy: randomized placebo-controlled study in childhood acute lymphoblastic leukemia. Am J Hematol. 1994 Sep; 47(1):27-32. PMID: 8042612.
      View in: PubMed
    250. Blanchette V, Walker I, Gill P, Adams M, Roberts R, Inwood M. Hepatitis C infection in patients with hemophilia: results of a national survey. Canadian Hemophilia Clinic Directors Group. Transfus Med Rev. 1994 Jul; 8(3):210-7. PMID: 8081082.
      View in: PubMed
    251. Collins AF, Gonçalves-Dias C, Haddad S, Talbot R, Herst R, Tyler BJ, Zuber E, Blanchette VS, Olivieri NF. Comparison of a transfusion preparation of newly formed red cells and standard washed red cell transfusions in patients with homozygous beta-thalassemia. Transfusion. 1994 Jun; 34(6):517-20. PMID: 8023393.
      View in: PubMed
    252. Calderwood S, Blanchette V, Doyle J, Freedman J, Stroncek D, Zipursky A. Idiopathic thrombocytopenia and neutropenia in childhood. Am J Pediatr Hematol Oncol. 1994 May; 16(2):95-101. PMID: 8166375.
      View in: PubMed
    253. Andrew M, Marzinotto V, Massicotte P, Blanchette V, Ginsberg J, Brill-Edwards P, Burrows P, Benson L, Williams W, David M, et al. Heparin therapy in pediatric patients: a prospective cohort study. Pediatr Res. 1994 Jan; 35(1):78-83. PMID: 8134203.
      View in: PubMed
    254. Blanchette VS, Luke B, Andrew M, Sommerville-Nielsen S, Barnard D, de Veber B, Gent M. A prospective, randomized trial of high-dose intravenous immune globulin G therapy, oral prednisone therapy, and no therapy in childhood acute immune thrombocytopenic purpura. J Pediatr. 1993 Dec; 123(6):989-95. PMID: 8229536.
      View in: PubMed
    255. Johnson JM, McFarland JG, Blanchette VS, Freedman J, Siegel-Bartelt J. Prenatal diagnosis of neonatal alloimmune thrombocytopenia using an allele-specific oligonucleotide probe. Prenat Diagn. 1993 Nov; 13(11):1037-42. PMID: 8140066.
      View in: PubMed
    256. McFarland JG, Blanchette V, Collins J, Newman PJ, Wang R, Aster RH. Neonatal alloimmune thrombocytopenia due to a new platelet-specific alloantibody. Blood. 1993 Jun 15; 81(12):3318-23. PMID: 8507868.
      View in: PubMed
    257. Levy GJ, Strauss RG, Hume H, Schloz L, Albanese MA, Blazina J, Werner A, Sotelo-Avila C, Barrasso C, Blanchette V, et al. National survey of neonatal transfusion practices: I. Red blood cell therapy. Pediatrics. 1993 Mar; 91(3):523-9. PMID: 8441554.
      View in: PubMed
    258. Strauss RG, Levy GJ, Sotelo-Avila C, Albanese MA, Hume H, Schloz L, Blazina J, Werner A, Barrasso C, Blanchette V, et al. National survey of neonatal transfusion practices: II. Blood component therapy. Pediatrics. 1993 Mar; 91(3):530-6. PMID: 8382782.
      View in: PubMed
    259. Blanchette VS, Hume HA, Levy GJ, Luban NL, Strauss RG. [Recommendations for controlling transfusions in pediatrics]. Gematol Transfuziol. 1993 Mar; 38(3):33-7. PMID: 8020735.
      View in: PubMed
    260. Strauss RG, Blanchette VS, Hume H, Levy GJ, Schloz L, Blazina JF, Werner AL, Sotelo-Avila C, Barrasso C, Hines D. National acceptability of American Association of Blood Banks Pediatric Hemotherapy Committee guidelines for auditing pediatric transfusion practices. Transfusion. 1993 Feb; 33(2):168-71. PMID: 8430458.
      View in: PubMed
    261. Atlas E, Freedman J, Blanchette V, Kazatchkine MD, Semple JW. Downregulation of the anti-HLA alloimmune response by variable region-reactive (anti-idiotypic) antibodies in leukemic patients transfused with platelet concentrates. Blood. 1993 Jan 15; 81(2):538-42. PMID: 8422470.
      View in: PubMed
    262. Robieux I, Eliopoulos C, Hwang P, Greenberg M, Blanchette V, Olivieri N, Klein N, Koren G. Pain perception and effectiveness of the eutectic mixture of local anesthetics in children undergoing venipuncture. Pediatr Res. 1992 Nov; 32(5):520-3. PMID: 1480451.
      View in: PubMed
    263. Rock G, Shumak K, Kelton J, Blanchette VS, Buskard N, Nair R, Spasoff R. Thrombotic thrombocytopenic purpura: outcome in 24 patients with renal impairment treated with plasma exchange. Canadian Apheresis Study Group. Transfusion. 1992 Oct; 32(8):710-4. PMID: 1412677.
      View in: PubMed
    264. Blanchette VS, Kirby MA, Turner C. Role of intravenous immunoglobulin G in autoimmune hematologic disorders. Semin Hematol. 1992 Jul; 29(3 Suppl 2):72-82. PMID: 1509297.
      View in: PubMed
    265. Andrew M, Blanchette VS, Adams M, Ali K, Barnard D, Chan KW, DeVeber LB, Esseltine D, Israels S, Korbrinsky N, et al. A multicenter study of the treatment of childhood chronic idiopathic thrombocytopenic purpura with anti-D. J Pediatr. 1992 Apr; 120(4 Pt 1):522-7. PMID: 1313096.
      View in: PubMed
    266. Coppes MJ, Zandvoort SW, Sparling CR, Poon AO, Weitzman S, Blanchette VS. Acquired von Willebrand disease in Wilms' tumor patients. J Clin Oncol. 1992 Mar; 10(3):422-7. PMID: 1311024.
      View in: PubMed
    267. Lillicrap D, Murray EW, Benford K, Blanchette VS, Rivard GE, Wensley R, Giles AR. Recurring mutations at CpG dinucleotides in the region of the von Willebrand factor gene encoding the glycoprotein Ib binding domain, in patients with type IIB von Willebrand's disease. Br J Haematol. 1991 Dec; 79(4):612-7. PMID: 1772783.
      View in: PubMed
    268. Rock GA, Shumak KH, Buskard NA, Blanchette VS, Kelton JG, Nair RC, Spasoff RA. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group. N Engl J Med. 1991 Aug 08; 325(6):393-7. PMID: 2062330.
      View in: PubMed
    269. Blanchette VS, Vorstman E, Shore A, Wang E, Petric M, Jett BW, Alter HJ. Hepatitis C infection in children with hemophilia A and B. Blood. 1991 Jul 15; 78(2):285-9. PMID: 1712646.
      View in: PubMed
    270. Blanchette VS, Hume HA, Levy GJ, Luban NL, Strauss RG. Guidelines for auditing pediatric blood transfusion practices. Am J Dis Child. 1991 Jul; 145(7):787-96. PMID: 1647658.
      View in: PubMed
    271. Blanchette VS, Sacher RA. Intravenous immunoglobulin: more questions than answers. Transfus Med Rev. 1991 Jul; 5(3):165-70. PMID: 1821177.
      View in: PubMed
    272. Freedman J, Blanchette V, Hornstein A, Farkas S, Milner R, Adams M, Lim FC, Garvey MB, Hannach B. White cell depletion of red cell and pooled random-donor platelet concentrates by filtration and residual lymphocyte subset analysis. Transfusion. 1991 Jun; 31(5):433-40. PMID: 2048181.
      View in: PubMed
    273. Imbach P, Tani P, Berchtold W, Blanchette V, Burek-Kozlowska A, Gerber H, Jacobs P, Newland A, Turner C, Wood L, et al. Different forms of chronic childhood thrombocytopenic purpura defined by antiplatelet autoantibodies. J Pediatr. 1991 Apr; 118(4 Pt 1):535-9. PMID: 2007927.
      View in: PubMed
    274. Blanchette VS, Sparling C, Turner C. Inherited bleeding disorders. Baillieres Clin Haematol. 1991 Apr; 4(2):291-332. PMID: 1912663.
      View in: PubMed
    275. Blanchette V, Doyle J, Andrew M. Haematological investigation in neonates. Baillieres Clin Haematol. 1990 Oct; 3(4):1019-54. PMID: 2271791.
      View in: PubMed
    276. Chan W, Petric M, Wang E, Koren G, Read S, Blanchette V. Response to hepatitis B immunization in children with hemophilia: relationship to infection with human immunodeficiency virus type 1. J Pediatr. 1990 Sep; 117(3):427-30. PMID: 2391599.
      View in: PubMed
    277. Strauss RG, Sacher RA, Blazina JF, Blanchette VS, Schloz LM, Butch SH, Hume H, Levy GJ, McMican A, Sotelo-Avila C. Commentary on small-volume red cell transfusions for neonatal patients. Transfusion. 1990 Jul-Aug; 30(6):565-70. PMID: 2378026.
      View in: PubMed
    278. Sacher RA, Strauss RG, Luban NL, Feil M, Anstall HB, Barnes A, Blanchette VS, Butch SH, Hume HA, Kevy SV, et al. Blood component therapy during the neonatal period: a national survey of red cell transfusion practice, 1985. Transfusion. 1990 Mar-Apr; 30(3):271-6. PMID: 2316004.
      View in: PubMed
    279. Blanchette VS, Chen L, de Friedberg ZS, Hogan VA, Trudel E, Décary F. Alloimmunization to the PlA1 platelet antigen: results of a prospective study. Br J Haematol. 1990 Feb; 74(2):209-15. PMID: 2317456.
      View in: PubMed
    280. Strauss RG, Barnes A, Blanchette VS, Butch SH, Hume HA, Levy GJ, McMican A, Starling K, Mauer A. Directed and limited-exposure blood donations for infants and children. Transfusion. 1990 Jan; 30(1):68-72. PMID: 2296794.
      View in: PubMed
    281. Jenkin D, Doyle J, Berry M, Blanchette V, Chan H, Doherty M, Freedman M, Greenberg M, Panzarella T, Saunders F, et al. Hodgkin's disease in children: treatment with MOPP and low-dose, extended field irradiation without laparotomy. Late results and toxicity. Med Pediatr Oncol. 1990; 18(4):265-72. PMID: 2355885.
      View in: PubMed
    282. Lillicrap DP, Taylor SA, Schuringa PC, Blanchette VS, Lovsted JK, Weiler LJ, Bridge PJ. Variation of the non-factor VIII sequences detected by a probe from intron 22 of the factor VIII gene. Blood. 1990 Jan 01; 75(1):139-43. PMID: 1967212.
      View in: PubMed
    283. Berchtold P, McMillan R, Tani P, Sommerville-Nielsen S, Blanchette VS. Autoantibodies against platelet membrane glycoproteins in children with acute and chronic immune thrombocytopenic purpura. Blood. 1989 Oct; 74(5):1600-2. PMID: 2790189.
      View in: PubMed
    284. Blanchette VS, Sacher RA, Ballem PJ, Bussel JB, Imbach P. Commentary on the management of autoimmune thrombocytopenia during pregnancy and in the neonatal period. Blut. 1989 Jul; 59(1):121-3. PMID: 2752167.
      View in: PubMed
    285. Blanchette V, Andrew M, Perlman M, Ling E, Ballin A. Neonatal autoimmune thrombocytopenia: role of high-dose intravenous immunoglobulin G therapy. Blut. 1989 Jul; 59(1):139-44. PMID: 2752172.
      View in: PubMed
    286. Freedman J, Gafni A, Garvey MB, Blanchette V. A cost-effectiveness evaluation of platelet crossmatching and HLA matching in the management of alloimmunized thrombocytopenic patients. Transfusion. 1989 Mar-Apr; 29(3):201-7. PMID: 2493693.
      View in: PubMed
    287. Doyle JJ, Koren G, Cheng MY, Blanchette VS. Anticoagulation with sodium warfarin in children: effect of a loading regimen. J Pediatr. 1988 Dec; 113(6):1095-7. PMID: 3193316.
      View in: PubMed
    288. Taylor SA, Lillicrap DP, Blanchette V, Giles AR, Holden JJ, White BN. A complete deletion of the factor IX gene and new TaqI variant in a hemophilia B kindred. Hum Genet. 1988 Jul; 79(3):273-6. PMID: 2841226.
      View in: PubMed
    289. Freedman J, Garvey MB, Salomon de Friedberg Z, Hornstein A, Blanchette V. Random donor platelet crossmatching: comparison of four platelet antibody detection methods. Am J Hematol. 1988 May; 28(1):1-7. PMID: 3285667.
      View in: PubMed
    290. Blanchette VS. Intravenous immunoglobulin for neonatal alloimmune thrombocytopenia. J Pediatr. 1988 May; 112(5):842-3. PMID: 3361399.
      View in: PubMed
    291. Ballin A, Andrew M, Ling E, Perlman M, Blanchette V. High-dose intravenous gammaglobulin therapy for neonatal autoimmune thrombocytopenia. J Pediatr. 1988 May; 112(5):789-92. PMID: 2452244.
      View in: PubMed
    292. Gafni A, Blanchette VS. Screening for neonatal alloimmune thrombocytopenia: an economic perspective. Curr Stud Hematol Blood Transfus. 1988; (54):140-7. PMID: 3349817.
      View in: PubMed
    293. Blanchette VS. Neonatal alloimmune thrombocytopenia: a clinical perspective. Curr Stud Hematol Blood Transfus. 1988; (54):112-26. PMID: 3280252.
      View in: PubMed
    294. Stevens MC, Blanchette VS, Freedman MH, Sparling C, Kunicki TJ. A variant form of Bernard-Soulier syndrome: mild haemostatic defect associated with partial platelet GPIb deficiency. Clin Lab Haematol. 1988; 10(4):443-51. PMID: 2855048.
      View in: PubMed
    295. Grover H, Phillips MA, Lillicrap DP, Giles AR, Garvey MB, Teitel J, Rivard G, Blanchette V, White BN, Holden JJ. Carrier detection of haemophilia A using DNA markers in families with an isolated affected male. Clin Genet. 1987 Jul; 32(1):10-9. PMID: 2887317.
      View in: PubMed
    296. Wang EE, Read SE, Zuliani J, Blanchette VS. Assessment of lymph node size in hemophiliac children: observer agreement and association with serologic status to human immunodeficiency virus I. Pediatr Infect Dis J. 1987 Apr; 6(4):383-7. PMID: 3473425.
      View in: PubMed
    297. Mulligan LM, Grover HJ, Blanchette VS, Giles AR, Lillicrap DP, Phillips A, Holden JJ, White BN. Recombination between the factor VIII gene and the DXS52 locus gives the most probable genetic order as centromere-fra(X)-DXS15-DXS52-F8C-telomere. Am J Med Genet. 1987 Mar; 26(3):751-60. PMID: 3105317.
      View in: PubMed
    298. Zipursky A, Brown EJ, Watts J, Milner R, Rand C, Blanchette VS, Bell EF, Paes B, Ling E. Oral vitamin E supplementation for the prevention of anemia in premature infants: a controlled trial. Pediatrics. 1987 Jan; 79(1):61-8. PMID: 3540836.
      View in: PubMed
    299. Hogan VA, Blanchette VS, Rock G. A simple method for preparing neocyte-enriched leukocyte-poor blood for transfusion-dependent patients. Transfusion. 1986 May-Jun; 26(3):253-7. PMID: 3705144.
      View in: PubMed
    300. Goldstein R, Blanchette VS, Huebsch LB, McKendry RJ. Treatment of gold-induced thrombocytopenia by high-dose intravenous gamma globulin. Arthritis Rheum. 1986 Mar; 29(3):426-30. PMID: 3964319.
      View in: PubMed
    301. Blanchette VS, Turner C. Treatment of acute idiopathic thrombocytopenic purpura. J Pediatr. 1986 Feb; 108(2):326-7. PMID: 3944723.
      View in: PubMed
    302. Blanchette VS, Peters MA, Pegg-Feige K. Alloimmune thrombocytopenia. Review from a neonatal intensive care unit. Curr Stud Hematol Blood Transfus. 1986; (52):87-96. PMID: 3754505.
      View in: PubMed
    303. Blanchette VS, McCombie NE, Rock G. Factors that influence lymphocyte yields in lymphocytapheresis. Transfusion. 1985 May-Jun; 25(3):242-5. PMID: 4002308.
      View in: PubMed
    304. Blanchette VS, Dunne J, Steele D, McPhail S, Sklar S, Algom D, Richter MA, Rock G. Immune function in blood donors following short-term lymphocytapheresis. Vox Sang. 1985; 49(2):101-9. PMID: 4036082.
      View in: PubMed
    305. Rock G, Blanchette V, McCombie N, Tittley P. Comparative function of centrifugal apheresis devices. Vox Sang. 1985; 48(3):136-42. PMID: 3984299.
      View in: PubMed
    306. Blanchette V, Hogan V, Esseltine D, Hsu E, Luke B, Rock G. Evaluation of a simple immunodiffusion technique for quantitation of platelet-associated immunoglobulin G in childhood immune thrombocytopenias. Am J Pediatr Hematol Oncol. 1985; 7(2):125-31. PMID: 3939560.
      View in: PubMed
    307. Blanchette VS. Intravenous gamma-globulin (Sandoglobulin) therapy in the management of four patients with immune thrombocytopenic purpura. Vox Sang. 1985; 49 Suppl 1:32-41. PMID: 2416125.
      View in: PubMed
    308. Blanchette VS, Hogan VA, McCombie NE, Drouin J, Bormanis JD, Taylor R, Rock GA. Intensive plasma exchange therapy in ten patients with idiopathic thrombocytopenic purpura. Transfusion. 1984 Sep-Oct; 24(5):388-94. PMID: 6435294.
      View in: PubMed
    309. Blanchette VS, Gray E, Hardie MJ, MacMurray SB, Heick HM, Rock G. Hyperkalemia after neonatal exchange transfusion: risk eliminated by washing red cell concentrates. J Pediatr. 1984 Aug; 105(2):321-4. PMID: 6747768.
      View in: PubMed
    310. Blanchette VS, Zipursky A. Assessment of anemia in newborn infants. Clin Perinatol. 1984 Jun; 11(2):489-510. PMID: 6378489.
      View in: PubMed
    311. Rock GA, Blanchette VS, Wong SC. Storage of platelets collected by apheresis. Transfusion. 1983 Mar-Apr; 23(2):99-105. PMID: 6836703.
      View in: PubMed
    312. Zipursky A, Milner RA, Blanchette VS, Johnston MA. Effect of vitamin E therapy on blood coagulation tests in newborn infants. Pediatrics. 1980 Oct; 66(4):547-50. PMID: 7001332.
      View in: PubMed
    313. Kelton JG, Blanchette VS, Wilson WE, Powers P, Pai KR, Effer SB, Barr RD. Neonatal thrombocytopenia due to passive immunization: prenatal diagnosis and distinction between maternal platelet alloantibodies and autoantibodies. N Engl J Med. 1980 Jun 19; 302(25):1401-3. PMID: 7374697.
      View in: PubMed
    314. Lanes R, Blanchette V, Edwin C, Zahka K, Lee PA, Pakula LC, MacLean WC, Plotnick LP. Congenital hypopituitarism and conjugated hyperbilirubinemia in two infants. Am J Dis Child. 1978 Sep; 132(9):926-8. PMID: 685913.
      View in: PubMed
    315. Blanchette VS, Hallett JJ, Hemphill JM, Winkelstein JA, Zinkham WH. Abnormalities of the peripheral blood as a presenting feature of immunodeficiency. Am J Hematol. 1978; 4(1):87-92. PMID: 566031.
      View in: PubMed
    Blanchette's networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description